Skip to main content

Psychiatric Comorbidities in ADHD

Psychiatric Comorbidities in ADHD

Last updated:

Author: Ulrich Brennecke
Review 10/2024: Waldemar Zdero, M.A. in Psychology

People with ADHD often have the following psychiatric disorders as well (comorbid), listed in descending order of frequency among people with ADHD (as a percentage of people with ADHD) compared to the frequency among people without ADHD.

Among adults in the top 10% of ADHD symptom severity according to the ADHD-E scale, psychological distress occurred 6.99 times more frequently than among those without ADHD.1

A study found that 51.8% of people with ADHD had one or more comorbid mental health conditions.2
Another study conducted in Japan in 2019 found that 54.4% of children and adolescents with ADHD had comorbid ASD, and 60.9% of adults had a mood disorder (depression, etc.).3

The percentages in the headings should indicate the prevalence of comorbidity in ADHD. Example: 70 to 80% of children with ADHD suffer from sleep disorders, compared to 35 to 40% of children without ADHD. Unfortunately, the figures are currently mixed up and need to be corrected.

1. Learning Disabilities - Up to 92%

1.1. Learning Disabilities in Children - 10 to 92%

10–92% prevalence of comorbid conditions in children with ADHD4/general learning disability (approx. 20%)56

1.2. Learning disabilities in adults - 2% (vs. 1.6%)

Total adults: 1.6%; women: 1.4%, men: 2.4%; ADHD-I: 1.5%, ADHD-C: 2.5%, ADHD-HI: 2.5%7

2. Autism Spectrum Disorders (ASD) — 3.6% to 85% (vs. 0.40% for girls to 1.85% for boys)

People with ADHD are at high risk for comorbid ASD.

  • 15- to 21-fold increased risk (based on a population prevalence of ASA of 1%) (meta-analysis)8
    • 15% to 21% of children and adolescents with ADHD have an autism spectrum disorder
    • Children with ADHD who also have ASD exhibit more severe ADHD symptoms than children without ASD
  • 8.07 times higher risk for children with ADHD (OR = 8.07)9
  • 24% of children with ADHD met the criteria for ASD10
  • 23% among adults with ADHD (small study, N = 105)11
  • a 31% to 37% increased risk of ASA12

Children with ADHD who had not been diagnosed with ASD exhibited increased ASD traits13, which was associated with negative outcomes in interpersonal, academic, and cognitive domains14.
The level of autistic traits in children without ASD can be measured using the CBCL-AT scale.1516 The CBCL-AT scale is considered positive if the sum of the T-scores for the Withdrawal, Social Problems, and Thinking Problems subscales of the Child Behavior Checklist (CBCL) is 195 or higher. According to this criterion, 18.18% of children with ADHD without autism exhibited autistic traits, compared to 0.87% of children without ADHD (20.9-fold risk, +1,990%).16

  • 60% of children with ADHD exhibited ASD traits.1718
  • 11.3% diagnostic prevalence of ASD among n = 221,714 people with ADHD (average age 25.1 years) 19

People with ASD also have an increased risk of ADHD620 21 22 It was referred to as:

  • 85%23
  • 78% (among N = 83 children with ASD, Asperger’s, and pervasive developmental disorder)24
  • 26% (study of N = 103 children, 85% of whom were boys with ADHD without intellectual disabilities—in 27 of these cases, previously undiagnosed ASD was identified)25
  • 21.6% of people with ADHD had comorbid ADHD26
  • 3.6% across the entire age range (cohort study)27

The DSM-IV still stipulated that ADHD and autism spectrum disorders should not be diagnosed as comorbid disorders. This was changed in the DSM-5.

In a large study, girls with autism who also had ADHD showed significantly more severe symptoms of ADHD, learning disabilities, and ODD than boys with ASD and ADHD.28

In the general population, ASS occurs in 1 out of 54 boys (1.85%) and in 1 out of 252 girls (0.40%).29

There is evidence that ADHD and autism have common genetic roots.3012 ADHD and ASD share two genes that are known as risk genes.20 There is speculation that ADHD and autism may have additional common genetic roots.30 In ASD, disorders in dopaminergic neurotransmission are suspected, among other things,31 while such disorders have been proven in ADHD.

Approximately 28%32 to 50% of people with autism have ADHD as a comorbid condition.
The fact that, according to DSM-IV, ADHD was not to be diagnosed in cases of autism contradicts empirical evidence and has therefore been omitted from the DSM-5.21

3. Sleep Disorders - Up to 80%

A Swedish registry study found that people with ADHD in all age groups had a 6.4- to 16.2-fold increased risk of being diagnosed with a sleep disorder and a 12- to 129.4-fold increased risk of being prescribed sleep medication.33

3.1. Sleep Disorders in Children with ADHD - 70 to 80% (vs. 35 to 40% = +100%)

70–80%34; 73.3% (28.5% mild plus 44.8% moderate and severe),356 twice as common as in people with ADHD3637
For the treatment of sleep disorders Sleep Problems in ADHD.

A meta-analysis found that approximately 33% of all people with narcolepsy also have ADHD.38
Narcolepsy is associated with reduced dopamine levels in the cerebrospinal fluid. This is consistent with the dopamine deficiency seen in ADHD. In dogs with narcolepsy, however, elevated dopamine levels have been found in the amygdala and elevated norepinephrine levels in the oral pontine reticular nucleus. Nevertheless, these dogs respond to stimulants that increase dopamine and norepinephrine.39
Kooij reports that 43% of people with ADHD experience sleep disturbances (difficulty falling asleep or staying asleep).40

3.2. Sleep disorders in adults with ADHD - 11.3% (vs. 2.3%)

Sleep problems that last longer than a month are called sleep disorders.

  • Among adults with ADHD: 11.3%41 to 29%42
  • Among those not affected: 2.3%41
    = a 5- to 12-fold increased risk

The annual prevalence of sleep disorders in Germany in 2008 ranged from 0.6% (ages 15 to 19) to 6.6% (ages 60 and older) for men and 0.8% (ages 15 to 19) to 7.8% (ages 60 and older) for women.43
Sleep problems are extremely common in people with ADHD:

  • 70–80% of children with ADHD have trouble sleeping
  • 20–30% of people with ADHD suffer from sleep problems
    Of the 670 adults with ADHD (with a medical diagnosis) who took the ADxS.org online symptom test, 69% reported sleep disturbances, compared with 39% of the 159 people with ADHD who stated they were definitely not affected (as of March 1, 2022).

A meta-analysis found that approximately 33% of all people with narcolepsy also had ADHD.38

3.3. Consequences of Sleep Disorders (Sleep Disorders: Children 47.1%; Adults: 0.6 to 7.8%)

A Chinese study of 23,791 schoolchildren found that 68.7% of children with ADHD had poor sleep quality, compared with 47.1% of children without ADHD.44

See also: ADHD – Comorbidity, specifically regarding sleep problems

When it comes to sleep problems and ADHD, it is difficult to distinguish between cause and effect. ADHD very often causes sleep disturbances, and sleep disturbances often cause ADHD-like symptoms.

When ADHD is diagnosed, comorbid sleep disorders should always be treated as a top priority. In addition, when prescribing medications for sleep problems, their potential negative impact on ADHD symptoms must be taken into account, just as medications for ADHD must be evaluated to ensure they do not exacerbate these sleep problems. More on treating sleep problems in ADHD: Treatment of Sleep Problems in ADHD

  • Disorders of alertness associated with impairments in sleep-wake regulation4546
  • Consequences of sleep apnea syndrome47
    “Obstructive sleep apnea syndrome (OSAS) is the most common sleep-related breathing disorder. Its prevalence is approximately 4% among men and approximately 2% among women.
    ** -obstructive sleep apnea (OSA) is even more common and reaches strikingly high rates, particularly when subgroups are considered. For example, the prevalence is approximately 36% among patients with diabetes mellitus or hypertension, 50% among obese patients, and 83% among patients with treatment-resistant hypertension. Estimates suggest that 80% of male and 90% of female patients with sleep apnea syndrome remain undiagnosed and are therefore not receiving treatment .” **48
    Sleep-related breathing pauses in children can lead to cognitive strain, which can cause symptoms similar to those of ADHD.49
  • chronic sleep deprivation45
  • Disorders in the sleep-wake cycle can cause the following within a few days:
    • increased irritability50
    • increased impulsivity50
    • reduced concentration51
    • reduced attention51
    • Working memory disorders52

Common symptoms of sleep problems and ADHD:53

  • motor hyperactivity, physical restlessness
  • Difficulty concentrating
  • Attention problems

ADHD symptoms that are atypical for sleep problems:

  • Inner restlessness (typical of atypical depression, less common in melancholic depression)
  • Impulsivity
  • excessive talkativeness (logorrhea, polyphasia)
  • Racing thoughts, ruminating
  • rapid mood swings
  • Dysphoria due to inactivity

Symptoms of sleep problems that are atypical for ADHD:

  • Drowsiness
  • (Daytime) fatigue

4. Mood Disorders (Depression / Dysphoria / Dysthymia / Mania / Bipolar Disorder) - 30 to 61% (vs. 4.7 to 8.9% = +550%)

Dysphoria associated with inactivity is a core symptom of ADHD and not a symptom of depression. Treating dysphoria associated with inactivity with antidepressants would constitute medical malpractice.
Depression and Dysphoria in ADHD
Of 70 adults with ADHD, 60.7% had experienced a mood disorder at some point in their lives, compared with 25.7% of those without ADHD.54

4.1. Depression

Depression was found

  • According to a large Swedish cohort study, 42.28% (men: 35.60%; women: 40.27%) of adults with ADHD, compared to 4.69% (men: 3.55%; women: 5.87%) of people without ADHD.55

  • According to another cohort study, 29.9% (across the entire age range) and 55.7% vs. 24.3% in a small study of adults with ADHD.54
    27

  • A Norwegian cohort study found major depression in 24.5% (men: 20.3%; women: 28.8%) of adults with ADHD, compared with 5.8% (men: 4%; women: 7.6%) of those without ADHD.56

  • For children with ADHD:

    • 37%5758
    • 37.34% (vs. 7.42% among people with ADHD) = 5 times the risk of depression or an anxiety disorder59
  • for children who are not affected: 8.9%58 –14% 57
    = four times the risk

  • 19.5% diagnostic prevalence of depression/bipolar disorder among n = 221,714 people with ADHD (average age 25.1 years)

  • Mood swings (15–75%)60

  • depressive disorders6

  • A simple survey conducted by www.adhs-chaoten.net, in which 73 people with ADHD took part, found that a majority suffer from seasonal fall-winter depression.61 This is very often a consequence of a vitamin D3 deficiency.
    Vitamin D3

  • Among adults with ADHD: 61.8%41;

    • Depression (40 to 60%)62; 25%42
  • Major depressive disorder (MDD)

    • 32%63
    • at least once in their lifetime for 26.4% of adults with ADHD, compared with 16.2% of people without ADHD64
    • Major Depression (6%)63
      = 4 to 5 times the risk
  • Depression (adults with ADHD overall: 21.4%; women 32.1%, men 19.8%; ADHD-I 22.3%, ADHD-C 17.6%, ADHD-HI 32.5%)65

  • The prevalence of major depression in the general population is 7.8%. Among people with ADHD, the prevalence is 18.6%, which is 2.4 times higher.66

  • Among adults in the top 10% of ADHD symptom severity according to the ADHD-E scale, the incidence of depression is 6.68 times higher than among those without ADHD.1

  • A meta-analysis found depression among people with ADHD and those without ADHD:67

    • in the general population at
      • 8.6% to 55% of people with ADHD vs. 1.2% to 12.5% of those without ADHD
    • in clinical cases involving
      • 15.4% to 39.7% of people with ADHD vs. 5.8% to 39.6% of people without ADHD
  • Predictors of comorbid depressive symptoms in adults with ADHD include

    • female gender
      • Women with ADHD had a 3.69-fold increased risk of depression. Women with ADHD who used hormonal birth control (the “pill”) had a 5.19-fold increased risk of depression.68
    • Cyclothymic affective temperament and few positive coping strategies69
    • emotional dysregulation and a dysthymic temperament70

4.2. Dysthymia 6.3% (vs. 3.4%)

Dysthymia was found in:

  • Total number of adults with ADHD: 7.3%; women 9.4%, men 5.4%; ADHD-I 6.3%, ADHD-C 7.6%, ADHD-HI 15%)65

  • at least once in their lifetime among 6.1% of adults with ADHD, compared with 3.4% of people without ADHD64

  • The prevalence of dysthymia in the general population is 1.9%. Among people with ADHD, the prevalence is 12.8%, which is 6.7 times higher.66

  • Dysthymia: 5.7% vs. 1.4%.54

4.3. Bipolar Disorders - 4.7% to 33.5% (vs. 3.1% to 14.3%)

Bipolar Disorders (“manic/depressive”):

  • 33.5% of adults with ADHD, compared with 6.2% of people without ADHD, at least once in their lives64

  • 19.4% among persons with ADHD; 3.1% prevalence in the general population, meaning a 6.3-fold increase.66

  • 6.4% of adults with ADHD overall (women 8.3%, men 4.7%; ADHD-I 5.1%, ADHD-C 8.0%, ADHD-HI 10.0%)65

  • 6%42

  • 4.7% (across the entire age range)27

  • Among adult psychiatric inpatients with ADHD: 92.2%71

  • Among those not affected: 14.3%41

  • Mania 0.15% (in ADHD across the entire age range)2

  • Between 57% and 86% of children and adolescents with bipolar disorder also have ADHD72

One hypothesis (which has not been experimentally validated) views bipolar disorder as an extreme form of ADHD-C. This hypothesis views ADHD and bipolar disorder as disorders of the self-regulation of extracellular dopamine levels:73
According to this theory, ADHD—like bipolar disorder—is characterized by a disorder in the self-regulation of extracellular dopamine levels, such that the DATs operate partially or completely in a mode of inappropriately high dopamine efflux; however, either the range between the lower and upper regulatory limits (where other factors intervene to stabilize dopamine levels) or the DAT homeostasis feedback loop is different. Bipolar disorder has a much narrower range of functional extracellular dopamine levels than ADHD. While ADHD-HI remains emotionally balanced at an elevated extracellular dopamine level and ADHD-I remains emotionally balanced at a reduced extracellular dopamine level, regulation can be achieved solely through D2 autoreceptor regulation.
However, without utilizing the appropriate autoregulation of extracellular dopamine levels, ADHD-C is said to be
When a certain number of DATs are operating in efflux mode, this results in a high extracellular dopamine level. The D2 autoreceptor can regulate this level to varying degrees, resulting in a state with high extracellular dopamine levels (ADHD-HI) or low extracellular dopamine levels (ADHD-I). In ADHD-C, by contrast, extracellular dopamine levels fluctuate between excessively high and excessively low values. Bipolar disorder differs from ADHD-C in that extracellular dopamine levels are even higher than in ADHD-HI and the upper limit of ADHD-C, and even lower than in ADHD-I and the lower limit of ADHD-C. An extremely high extracellular dopamine level in bipolar disorder correlates with a manic phase, while an extremely low level correlates with a depressive phase.
In our view, the following are points of criticism regarding this model:

  • In ADHD-C, inattentive and hyperactive-impulsive symptoms occur simultaneously, whereas bipolar disorder involves clear shifts between manic and depressive episodes.
  • The hypothesis model does not distinguish between different brain regions.
  • From our perspective, it is more conceivable that extracellular dopamine levels in ADHD-C exhibit different states simultaneously in various regions of the brain.
  • Not all people with bipolar disorder also have ADHD, but that would have to be the case if bipolar disorder were simply a more severe form of ADHD-C
  • Amphetamine-based medications are more effective than methylphenidate in adults with ADHD. Amphetamine causes DAT efflux—a confirmed effect at higher (drug) doses, though it is unclear whether this also occurs at therapeutic doses. If amphetamine also causes DAT efflux at therapeutic doses, then, according to the hypothesis, it should exacerbate ADHD symptoms.

Cyclothymia is another form of affective disorder in which bipolar mood swings occur at shorter intervals and are less severe than in bipolar disorder.
From our perspective, cyclothymia would therefore be a more likely candidate for a “milder” form of bipolar disorder than ADHD.

5. Motor clumsiness up to 60%

Source6

5.1. Developmental Coordination Disorder (DCD) - 29% to 47%

  • 47% have developmental coordination disorder (DCD, dyspraxia) among people with ADHD7475
  • over 50%. An online survey of German parents (n = 149) found a significantly higher prevalence of DCD (over 50%), even among parents who had never heard of DCD.76
  • 34% of boys and 29% of girls with ADHD (n = 755)77

Children with DCD were more likely to exhibit ADHD symptoms.78
In an online survey of university students (aged 29 and under) in Japan, 7.4% of participants were found to have dyspraxia (≥ 32 points on the AAC-Q, mean 36.2). 17.6% scored ≥ 27 points. Participants without DCD scored an average of 19.5 points. ADHD was found in 3.2% of participants. The AAC-Q scores correlated strongly with the results of the ADHD Developmental Disorder Difficulty Scales Short (r = 0.65), moderately to strongly with the ASD Developmental Disorder Difficulty Scales (short form) (r = 0.55), and moderately with mental health problems as measured by the UPI (r = 0.41). These findings are consistent with other studies that have identified DCD in 7 to 9% of all young adults.79

A combination of ADHD and DCD usually represents a more severe phenotype. Despite some shared neural characteristics, ADHD and DCD appear to have distinct etiologies.75

Diagnostic criteria according to DSM-5:

  1. The ability to learn and perform coordinated motor skills (when given the opportunity to learn these skills) is below the level expected for the child’s age.
  2. Motor difficulties significantly impair activities of daily living and affect academic performance, pre-vocational and vocational activities, as well as leisure and play.
  3. It begins in the early stages of development.
  4. A doctor cannot better explain the motor difficulties by citing an intellectual disability, a visual impairment, or other neurological conditions that affect movement.

The delay usually involves the development of motor skills. Motor milestones are often not delayed.

5.2. Children with gross motor skill difficulties

Frequent accidents, bumping into things, bruises. See also “Symptoms of ADHD.”

5.3. Impaired fine motor skills, poor handwriting - 60%

Up to 60% of people with ADHD have impaired fine motor skills, such as poor handwriting.80

6. Behavioral disorders / social disorders (aggression, antisocial behavior, oppositional defiant disorder) — up to 55%

  • 30 to 50% of people with ADHD also have ODD or CD.81
  • 30% of adults with ADHD exhibited some form of social behavior disorder82

6.1. Severe Behavioral Disorders (Disruptive Behavior Disorders) - 30 to 50%

Prevalence of DBD in Children with ADHD:

  • 50%83
  • 30 to 50% of people with ADHD also have ODD or CD.81
  • 31% in Iran among children aged 6 to 18.84

Recent models for defining externalizing aggressive disorders include

  • Disruptive Mood Dysregulation Disorder (DMDD)85 and
  • Intermittent Explosive Disorder (IED)81

6.2. Deficient Emotional Self-Regulation (DESR) - 44 to 55%

DESR is described as

  1. Deficits in self-regulation resulting from physiological arousal triggered by strong emotions
  2. Difficulty inhibiting inappropriate behavior in response to positive or negative emotions
  3. Difficulty refocusing attention during intense emotions
  4. Disruption of behavioral coordination in response to emotional arousal
  • DESR differs from the persistent and severe aggressive irritability that is common in (rare) pediatric bipolar disorder.86
  • The abnormal moods associated with bipolar disorder are not due to a lack of self-control and include additional mood criteria as defined by the DSM-IV. DESR is not associated with an increased risk of bipolar disorder.87

Among people with ADHD, DESR was found in

  • 55%88

  • 44%87

  • in 2% of people without ADHD.87

DESR is diagnosed when people with ADHD score between 180 and 210 points on the three scales—anxiety/depression (intense emotions), aggression, and attention (impulsivity)—of the Child Behavior Checklist (CBCL) (an average of between 60 and 70 per scale). Scores above 210 points are no longer classified as DESR but rather as more severe forms of affective disorders (disorders involving dysregulation of mood and behavior). Given the defined diagnostic criteria for DESR—which cannot be met without a high score on the aggression scale—the diagnosis of DESR is likely limited to the ADHD-HI subtype, which phenotypically tends to respond to perceived stress with aggression.
The CBCL scale for aggressive behavior assesses:89

  1. Argues or disagrees a lot
  2. Indicates, cuts to
  3. If she is rude or mean to others, she intimidates them
  4. Requires a lot of attention
  5. Breaks his own stuff
  6. Break things that belong to parents, siblings, or others
  7. Don’t Obey at Home
  8. Don’t disobey at school
  9. Gets jealous easily
  10. Tends to get into scuffles and arguments
  11. Physically attacks others
  12. Talk a lot
  13. Likes to show off or clown around
  14. Is stubborn, grumpy, or irritable; gets annoyed easily by others
  15. Shows sudden changes in mood and emotions
  16. Talk too much
  17. Likes to tease others
  18. Has outbursts of anger or a hot temper
  19. Threatens, harasses, or intimidates others
  20. Is unusually loud

In our assessment, all question topics primarily target the ADHD-HI subtype (with hyperactivity), while only question topics 7, 8, 9, 14, and 15 also apply to the ADHD-I subtype, but do not specifically assess its potential symptoms of inward-directed emotional intensity. In the predominantly inattentive subtype (ADHD-I), externalizing symptoms such as aggression or oppositional defiant behavior barely occur.90 To our understanding, the ADHD-I subtype internalizes perceived stress and does not primarily react aggressively.

With this set of symptoms, DESR can therefore only occur in people with ADHD-HI and ADHD-C, not in people with ADHD-I.
We assume that people with ADHD-I also suffer from emotional dysregulation, which simply does not—or rarely—manifest as aggression. An ADHD therapist confirmed this view during a personal conversation.

Consequently, significantly more than 44 to 55 percent of all people with ADHD are likely to suffer from emotional dysregulation, although the manifestations of this condition can vary widely.
Research on this topic would also be desirable, taking into account the subtypes and the phenotypic manifestations of intense emotions associated with each (ADHD-HI: externalizing / ADHD-I: internalizing).

6.3. Oppositional Defiant Disorder (ODD) - 26 to 53% (vs. 3.9% = +560% to +1,260%)

  • 60% ODD prevalence among children with ADHD82 We believe this figure has been misinterpreted. In our view, this might apply—if at all—only when considering boys with severe ADHD-HI. Furthermore, * The prevalence figures by gender do not match the overall prevalence cited:
    • 55% among boys
    • 30% among girls
    • 30% of adults with ADHD exhibit a range of social behavior disorders82
  • 53% among children and adolescents with ADHD-C91
    • 63% for ADHD-C and ASD91, with 80% of people with ADHD-C also exhibiting ASD
    • 28% for ADHD-I and ASD91
    • 24% for ASA91
    • 14% for ADHD-I91
  • 39.3% among children with ADHD92
  • 35% ODD in children with ADHD93
  • 26.1% among Iranian children with ADHD between the ages of 6 and 1884
  • 0.7% ODD among adults with ADHD (women 0.0%, men 1.7%; ADHD-I 0.0%, ADHD-C 1.5%, ADHD-HI 5.0%)65

ODD among those not affected: 3.9%41
= 8 to 15 times the risk

Children with ADHD had a 147.05-fold increased risk of oppositional defiant disorder (OR = 147.05)9

  • ODD primarily refers to ADHD-HI (with hyperactivity) and less so to people with ADHD-I (without hyperactivity), since hyperactivity is a manifestation of an externalizing stress response pattern, whereas ADHD-I is a manifestation of internalized stress (freezing, fleeing). The subtypes of ADHD: ADHD-HI, ADHD-I, SCT, and others
  • We view ODD (Oppositional Defiant Disorder) as a condition that is purely comorbid with ADHD, and therefore not as a symptom of ADHD.
    • On the one hand, Steinhausen describes social behavior disorders as the most common comorbidity of ADHD; on the other hand, *94 * Refers to this comorbidity on page 174 as a subtype of ADHD.
    • Aside from the fact that sleep disorders are likely to be significantly more common, we do not consider ODD to be a subtype because its genetic basis cannot be clearly distinguished.
      • A specific polymorphism of the MAO-A gene is cited as a contributing genetic factor for social behavior disorders as well as ADHD (in each case, as one of several interacting specific genes). However, with regard to social behavior disorders, this gene polymorphism appears to play a much greater role, as it is cited much more frequently in that context, whereas ADHD can manifest even without the involvement of this gene (through the interaction of other genes). In the case of ADHD, the MAO-A gene is consistently cited in a subset of people with ADHD who also suffer from behavioral disorders.
      • Another argument in favor of a purely comorbid condition is that medications not specifically indicated for ADHD, such as risperidone, merely reduce aggression but do not alleviate ADHD symptoms, whereas MPH (methylphenidate) can alleviate both ADHD and ODD symptoms equally.95
  • ODD does not correlate with any of the symptom clusters in the dual/triple-pathway model; thus, at least in this respect, it has a different neurological basis.96

Symptoms of Oppositional Defiant Disorder (ODD):

  • Frequent and persistent defiance or disobedience toward authority figures
  • Argumentative and easily irritated or annoyed
  • Deliberate attempts to annoy others or act in a vindictive manner
  • Difficulty following rules and exhibiting a pattern of negative, hostile, and defiant behavior

6.4. Social Behavior Disorders / Conduct Disorder (CD) — up to 20.2% (vs. 4.3%)

Conduct disorder (CD) is more common in ADHD.6

  • 20.2% of adults with ADHD, compared with 4.3% of people without ADHD, at least once in their lifetime64

  • 16% among children with ADHD (18% of boys, 8% of girls).82

  • 1.2% for adults with ADHD overall: 1.2%; women 0.7%, men 1.7%; ADHD-I 0.3%, ADHD-C 1.0%, ADHD-HI 10.0%65

People with a social behavior disorder are 21 times more likely (compared to persons without the disorder) to also have ADHD.97
Social behavior disorders and aggression disorders have their own genetic predisposition associated with a specific polymorphism in the MAO-A gene. How ADHD Develops: Genes or Genes + Environment

The prevalence of conduct disorder among children and adolescents was determined by an Iranian study to be:98

  • 0.58% among children ages 6 to 9
  • 0.57% among adolescents aged 10 to 14
  • 1.22% among adolescents aged 15 to 18

32% met the criteria for ADHD and ODD at the same time, while 55% met the criteria for ODD.

Symptoms of Conduct Disorder (CD):

  • Aggressive or violent behavior
    • Frequent physical altercations
    • Harm to people or animals
    • Bullying or cruelty
  • antisocial behavior
    • Frequent disregard for the rights of others
  • recurring and persistent patterns of difficulty in accepting social norms
    • Destruction of property
    • Involvement in thefts
    • fraudulent conduct
    • Lies
  • Lack of remorse or feelings of guilt for one’s own actions
    • lack of empathy

6.5. Aggressive behavior—over 50%

Just over 50%99

Aggressive behavior is not a primary symptom of ADHD-HI. Aggression can be a manifestation of stress, but not everyone reacts to stress with aggression, nor does everyone who tends to externalize stress do so.
One piece of evidence supporting the notion of pure comorbidity is that medications not specifically indicated for ADHD, such as risperidone, reduce aggression but not ADHD symptoms, whereas MPH (methylphenidate) can alleviate both ADHD and ODD symptoms equally.95

In cases of ADHD, reduced cortisol levels have been reported in conjunction with aggressive behavior.100
Externalizing stress responses are associated with reduced basal cortisol levels and a diminished cortisol response to acute stress.
Disorders in stress hormone levels, particularly cortisol, are extremely common in ADHD.
Cortisol in ADHD

See also Neurophysiological Correlates of Aggression

7. Anxiety disorders—up to 47% (vs. 19.5%)

47.1% among people with ADHD, which is approximately 2.4 times higher.66

24% diagnostic prevalence of anxiety and stress-related disorders among n = 221,714 people with ADHD (average age 25.1 years) 19

The prevalence of anxiety disorders in the general population is 19.5%.101
Generalized anxiety disorder (a type of anxiety disorder) affects up to 5% of children and adolescents and between 3% and 6% of adults.102

No genetic overlap was found between ADHD and anxiety disorders. Genes correlated with high intelligence were found to provide protection against ADHD, but not against anxiety disorders.103

7.1. Anxiety Disorders in Children - 25 to 38% (vs. 7 to 10% = up to +400%)

The prevalence of anxiety disorders among children with ADHD was:

  • 37.9% among Iranian children with ADHD between the ages of 6 and 18.84
  • 37.34% (vs. 7.42% among people with ADHD) = a 5-fold increased risk of depression or an anxiety disorder59
  • 37% across the entire age range27
  • 34%104
  • 25%105
  • 25% 93
  • increased (without a percentage)106
  • Children with ADHD had a 24.49-fold increased risk of anxiety disorders (OR = 24.49)9

The prevalence of anxiety disorders in the general population is

  • about 10%107
  • 7.42%59
    = 3 to 5 times the risk
  • Anxiety disorders and ADHD appear to reinforce each other. Treating anxiety or ADHD also reduces the symptoms of the other disorder.108
  • Generalized anxiety disorder increased the risk of ADHD by three and a half times, while ADHD quadrupled the risk of generalized anxiety disorder.109
  • 40 to 85% of children with an anxiety disorder also had ADHD110

7.2. Anxiety Disorders in Adults - 44% (vs. 4.9%)

According to a large Swedish cohort study, an anxiety disorder was found in

  • 4.3% to 47.1% of people with ADHD vs. 0.5% to 9.5% of those without ADHD (meta-analysis)67
  • 44.65% (men: 37.02%; women: 55.74%) of adults with ADHD, compared with 4.89% (men: 3.64%; women: 6.19%) of people without ADHD.55
  • 42%, or 20 to 60%, among adults with ADHD62
  • 34.3% of adults with ADHD at least once in their lives, compared with 25.7% of those without ADHD.54
  • 34.5% (19% anxiety disorders and 15.5% phobic disorders)42
  • 22.2% (men: 18.2%; women: 26.3%) of adults with ADHD, compared with 5% (men: 3.3%; women: 6.7%) of people with ADHD (Norwegian registry study)111

Among adult psychiatric inpatients with ADHD

  • 3.9% to 84% among people with ADHD who are hospitalized vs. 5.4% to 40% among people with ADHD who are hospitalized and psychiatric patients without ADHD (meta-analysis)67
  • 28.6%71
  • 25%105

Anxiety disorders and ADHD appear to exacerbate each other. Treating anxiety or ADHD also reduces the symptoms of the other Disorder.108

7.2.1. Generalized Anxiety Disorder - 5.9 to 25% (vs. 2%)

  • 8% among people with ADHD, compared with a prevalence of 2.6% in the general population—a roughly threefold increase.66

  • For adults with ADHD:

    • 25%63
    • 5.9% among adults with ADHD (women 7.6%, men 4.4%; ADHD-I 7.1%, ADHD-C 3.5%, ADHD-HI 7.5%65
    • 2.9% of adults with ADHD at least once in their lives, compared with 1.4% of those without ADHD.54

Prevalence in the general population: 2%63

7.2.2. Social phobia - 5 to 29.3% (vs. 3.5 to 10%)

  • 29.3% among people with ADHD, compared to a prevalence of 7.8% in the general population—a rate nearly 3.8 times higher.66
  • 22.8% of adults with ADHD have social anxiety disorder, compared with 6.6% of people with ADHD at least once in their lifetime.64
  • 18.6% of adults with ADHD at least once in their lives, compared with 10% of those without ADHD.54
  • 3.5% among adults with ADHD (women 2.5%, men 4.4%; ADHD-I 3.3%, ADHD-C 3.0%, ADHD-HI 7.5%)65

7.2.3. Panic Disorder - 1.9 to 4.3% (vs. 2.9%)

  • 22% of adults with ADHD, compared with 7% of people without ADHD, at least once in their lives64
  • 8.9% among persons with ADHD; the prevalence in the general population is 3.1%, meaning the rate is nearly three times higher.66
  • 4.3% of adults with ADHD have experienced it at least once in their lives, compared with 2.9% of those without ADHD.54
  • 1.9% of adults with ADHD (women 2.9%, men 2.4%; ADHD-I 2.1%, ADHD-C 2.5%, ADHD-HI 7.5%)65

7.2.4. Specific Phobias

  • 35.8% of adults with ADHD at least once in their lives, compared with 14.6% of people without ADHD 64

  • 22.7% among people with ADHD; the prevalence in the general population is 9.5%, meaning the rate is nearly 2.4 times higher.66

  • Agoraphobia:

    • 4.0% among persons with ADHD; prevalence in the general population is 0.7%, meaning the rate is approximately 5.7 times higher.66

8. Substance Abuse and Addiction—Up to 45%

A meta-analysis found substance use disorders:112

  • in the general population at
    • 2.3% to 41.2% of people with ADHD vs. 0% to 16.6% of people without ADHD
  • in clinical cases involving
    • 10% to 82.9% of people with ADHD vs. 2% to 72.2% of people without ADHD

9.3% diagnostic prevalence of substance use disorders among n = 221,714 people with ADHD (average age 25.1 years)

Among patients at addiction treatment centers, 21 to 23% are found to be people with ADHD in screening studies113, which is 4.6 to 9.2 times higher than the prevalence of ADHD in the general adult population (2.5 to 5%). One study found that 45% of people with ADHD114, which is 10 to 20 times higher than the general prevalence

8.1. Substance-Related Addictions / Substance Abuse

Of the N = 873 patients at a psychiatric emergency department in a rapidly growing urban district in North Carolina (U.S.) diagnosed with anxiety, depression, schizophrenia, ADHD, bipolar disorder, alcohol abuse, or schizoaffective disorder according to ICD-10, the following were observed:115

  • 58% of patients with a history of psychiatric illness tested positive on a urine drug test
  • ADHD (n = 135)
    • 34.7% alcohol
    • 20.2% THC
    • 15.3% cocaine
    • 14.9% acetaminophen
    • 12.9% benzodiazepines
    • 12.1% opiates
    • 8.1% amphetamine-type drugs
    • 1.6% barbiturates
  • Depression (n = 225)
    • 40.8% acetaminophen
    • 25.6% THC
    • 20.9% alcohol
    • 15.0% opiates
    • 13.7% benzodiazepines
    • 12.6% cocaine
    • 7.4% amphetamine-type drugs
    • 2.1% barbiturates
  • Anxiety
    • 30.8% THC
    • 10.3% alcohol
    • 5.1% opiates
    • 5.1% cocaine
    • 4.7% acetaminophen
  • bipolar disorders
    • 29.4% THC
    • 27.3% alcohol
    • 16.9% opiates
    • 13.0% cocaine
    • 10.4% benzodiazepines
    • 9.2% acetaminophen
    • 8.2% amphetamine-type drugs
  • Schizoaffective disorder (n = 245)
    • 26.1% THC
    • 25.6% alcohol
    • 24.4% acetaminophen
    • 20.8% cocaine
    • 12.1% benzodiazepines
    • 8.7% opiates
    • 5.1% amphetamine-type drugs
    • 2.5% barbiturates
  • Schizophrenia (n = 45)
    • 32.6% THC
    • 14.4% alcohol
    • 10.9% cocaine
    • 5.5% acetaminophen
    • 8.7% benzodiazepines
    • 2.2% opiates

Overall, no significant association was found between psychiatric diagnosis and a positive drug screen.115

8.1.1. Substance Abuse - 21.9% to 35% (vs. 2.9% to 3.6%)

  • 35.12% (men: 39.44%; women: 30.88%) of adults with ADHD, compared to 3.61% (men: 4.40%; women: 2.79%) of people without ADHD (large Swedish cohort study)55
  • 21.9% (men: 27.5%; women: 16.2%) of adults with ADHD, compared with 2.9% (men: 3.6%; women: 2.1%) of those without ADHD (large Norwegian cohort study)116

Among adult SUD patients at three drug rehabilitation centers in urban Malaysia, the prevalence of ADHD was 47.2%. Compared to people with ADHD, those with ADHD were less likely to have medical comorbidities (84.9% vs. 93.3%), were more likely to have a history of incarceration (80.8% vs. 65.6%), and were more likely to have been incarcerated for the first time before the age of 18 (24.6% vs. 16.8%).117

Substance abuse is a common comorbidity of ADHD.6 One possible explanation could be that dopamine deficiency leads to increased expression of CB1 cannabinoid receptors.118119 120 THC binds to CB1 receptors.

Of 70 adults with ADHD, 17.1% had a history of substance abuse, compared with 2.9% of those without ADHD.54
People with SUD had an ADHD prevalence of 21% (meta-analysis).121
Among 153 individuals with substance use disorders (98.7% men) at a clinic in India, 33% were diagnosed with ADHD. The prevalence of ADHD varied across specific types of substance use disorders:122

  • 47.6% of people with cannabis dependence

  • 38.8% of people who use tobacco or smoke

  • 33% of people with cocaine addiction and

  • 21.5% of people with alcohol dependence.

  • The prevalence of ADHD among people with opioid addiction was approximately 50%. ADHD symptoms, particularly impulsivity, increase the risk of opioid addiction. 123

  • Among people with ADHD, substance abuse begins, on average, 3 years earlier124

  • Appropriate medication (particularly methylphenidate) reduces the likelihood of addiction or substance abuse in people with ADHD.

  • People with ADHD and comorbid cocaine addiction showed a significant reduction in addictive behavior when treated with stimulants, corresponding to the decline in ADHD symptoms.125

A small Norwegian cohort study found no association between ADHD and alcohol or drug abuse,126, as did an earlier study,127, which found increased alcohol and drug abuse among people with ADHD only when additional externalizing disorders were present.
However, these studies are in clear contradiction to the vast majority of the scientific literature, which reports a significant increase in risk associated with ADHD.

8.1.2. Smoking - 40 to 45% (vs. 22 to 25%)

Among people with ADHD, [number] smoked

  • 44.8%64

  • 42%128129

  • 40% 130

  • 51% of adult psychiatric inpatients with ADHD are nicotine-dependent71

Among people without ADHD, smoking

  • 27% of women and 32% of men in the total population aged 18 and older131
  • 26% (2005)132
  • 22.6%64

According to the study, the risk of smoking is nearly doubled among people with ADHD (regardless of medication).
Among people with ADHD-HI or ADHD-C, the risk of smoking is doubled.133

ADHD medications, nicotine (smoking), and zinc block the dopamine transporters (DAT)—which are elevated in ADHD—and thereby reduce their overactivity134

8.1.3. Alcohol dependence (30 to 39% vs. 5 to 15%) / Alcohol abuse

German guidelines now recommend an ADHD evaluation as standard practice for individuals with alcohol addiction.

The risk of alcohol dependence is dramatically higher in people with ADHD.135

  • in people with ADHD
    • 38.9%64
    • 30%63, 25 to 44%133
    • 8.6% of adults with ADHD have experienced this at least once in their lives, compared with 2.9% of those without ADHD.54
    • 4.1% among adult psychiatric inpatients with ADHD71
  • among those not affected

= 6 to 8 times the risk

Conversely, among 153 alcoholics, 43% were found to have had ADHD in childhood and 22% were found to have persistent ADHD.136 Another study found that 19% of 100 adult alcohol-dependent individuals in India had been diagnosed with ADHD.137

Alcohol/Substance Abuse:

  • 1.6% of adults with ADHD exhibited alcohol or substance abuse (women 1.1%, men 2.0%; ADHD-I 0.9%, ADHD-C 2.5%, ADHD-HI 2.5%)65

  • 18.1% to 22.6%64 compared with 19.3% among those not affected64

  • A small Norwegian cohort study found no association between ADHD and alcohol or drug abuse,126, as did an earlier study,138, which found increased alcohol and drug abuse among people with ADHD only when additional externalizing disorders were present.

In cases of alcohol dependence, 6 parameters predicted the presence of comorbid ADHD with an AUC of 0.926:.135

  • reduced self-control
  • increased novelty seeking
  • Self-transcendence
  • Damage Prevention
  • Craving
  • earlier onset of alcohol use

Self-regulation and novelty seeking together achieved an accuracy of 85%.135

8.1.4. Substance-related addictions in general - 7.8%

  • Among adults with ADHD: 7.8%41, 20%63 to 50–60%139140
  • Among those not affected: 1.9%41 to 5%63140
    = 4 to 12 times the risk
  • According to another source, the lifetime prevalence of psychoactive substance use is 52% among people with ADHD and 24% among those without ADHD.141
  • Of 70 adults with ADHD, 11.4% had experienced substance dependence at some point in their lives, compared with 0% of the 70 adults without ADHD.54

8.1.5. Drug Addiction

  • The prevalence of drug addiction in the general population is 0.6%. Among people with ADHD, the prevalence is 4.4%, which is approximately 7.3 times higher.66
  • Among adult psychiatric inpatients with ADHD, 7.1% have comorbid substance use disorder.71
  • People with drug addiction are 4 to 5 times more likely to have ADHD142
  • 15.5%143 to 25% of all people with substance use disorders have ADHD144
  • ADHD was found in 11.2% of all adult patients with substance use disorders who used opioids intravenously or benzodiazepines intravenously or intranasally. The prevalence of ADHD was higher among women (15.3%) than among men (10.3%).145
  • For people with ADHD, the risk of substance dependence (addiction) is 2 to 3 times higher than for those without the condition.146
  • For people with ADHD, the risk of nicotine dependence is up to 9 times higher than for those without the condition.146
  • People with ADHD are about as likely to have an addiction as their relatives who do not have ADHD.
    • Cannabis: 67% vs. 72%140
    • Cocaine: 23% vs. 21%140
    • Stimulants: 18% vs. 10%140
    • Hallucinogens: 18% vs. 7%140
    • Opioids: 16% vs. 3%140
    • Sedatives: 14% vs. 10%140
  • According to a study, 12% of cocaine users had ADHD as children, and 10% still had it as adults.147

8.2. Behavioral Addiction / Gambling 5.3% (vs. 2.4%)

People with ADHD are more than twice as likely to develop a gambling addiction (5.3% versus 2.4%). Problem gambling is four times as common among people with ADHD (2.4%) as among persons without ADHD (0.6%).148
Another study found that 1.54% of adults with ADHD had experienced gambling addiction at least once in their lives, compared with 0.39% of people with ADHD.64

A study of N = 97 people with gambling addiction found a prevalence rate of ADHD of 26.0% and a prevalence rate of ASD of 29.8%.149
A study found that genetic variants associated with substance use may causally increase the risk of ADHD.150

8.3. Substance abuse (illegal drugs: 10%, nicotine: 16.6 to 25.5%)

Among people with ADHD, the prevalence of substance abuse is 33.5%.151 The risk of substance abuse among people with ADHD in the United States is 1.7 to 7.9 times higher.152

The prevalence of substance abuse among German adults in 2019 (12-month prevalence and lifetime prevalence) was:153
Cannabis: 7.1% / 28.3%
Cocaine / Crack: 1.1% / 4.1%
Ecstasy: 1.1% / 3.9%
Amphetamines: 1.2% / 3.8%
Methamphetamine / Crystal Meth: 0.2% / 0.8%
Smoking (at least 20 cigarettes per day), adults:154

  • Men: 25.5%
  • Women 16.6%

Alcohol:155

  • Risky use within the past 12 months
    • Men 15.6%
    • Women 12.8%

A study found a prevalence of ADHD of 20.5% among patients receiving inpatient treatment for alcohol dependence.156

If ADHD is accompanied by aggressive and oppositional-defiant behavior as well as low self-esteem, the likelihood of substance abuse is significantly increased, whereas no higher rate of substance abuse was observed among people with ADHD who did not exhibit these additional symptoms.157158

In our assessment, substance abuse is much more likely to be a consequence of ADHD than a cause of a full spectrum of ADHD symptoms. In rarer cases, it occurs as a comorbid condition. Treatment with stimulants very often eliminates the tendency toward addiction in ADHD. Modern formulations of stimulant medications are barely suitable for abuse as a drug (e.g., Vyvanse: a lysine-bound prodrug of amphetamine that is converted very slowly into the active ingredient only in the intestine).

In the Continuous Performance Test, people with ADHD showed more responses to the correct timing cues than people with substance use disorders.159

8.4. Addiction / Dependence (Alcohol: 5%, Gambling: 0.31%)

Prevalence: Occurs in 24.9% of adults with ADHD.160

Alcohol:155

  • Dependency
    • Men 4.8%
    • Women 2%
  • Abuse
    • Men 4.6%
    • Women 1.5%

In Berlin, 5.0% of respondents aged 15 to 64 met the criteria for alcohol dependence according to the DSM-IV (men: 6.4%, women: 3.5%).161

In Germany, the prevalence of gambling addiction is 0.31%, and the prevalence of problematic gambling behavior is 0.56%.162
A study of N = 97 people with gambling addiction found a prevalence rate of 26.0% for ADHD and 29.8% for ASD.149

When ADHD and addiction co-occur, there is a higher likelihood that ADHD is the underlying cause of the addiction, rather than the addiction being the cause of ADHD. This has been observed, at least, in the case of smoking, cannabis, and likely alcohol as well.163

A study found that elevated genetic risk scores for ADHD (polygenic risk scores, PRS) were associated with a 20% increased likelihood of substance use disorder. There were no differences in the severity of substance use (use, abuse, dependence) or the type of substances used (alcohol, cannabis, other illegal drugs). Conversely, the ADHD PRS accounted for only 0.2% of the probability of addiction compared to other risk factors.164

A study found a prevalence of ADHD of 16.7% among people with severe addiction, compared with 2.5% in the control group.165
Even more significant was the fact that 53% of severely addicted individuals exhibited socially disruptive behavior during childhood or adolescence (up to age 15), as measured by the SKID-II (compared to 2.5% of control subjects).166 An early social disorder (OR = 35.1), compared to childhood hyperkinetic behavior (OR = 5.7), represents by far the greater risk factor for severe addiction.167
To us, this suggests that addiction plays a greater role in ADHD-HI than in ADHD-I.
In terms of substance preferences, there are indications of more frequent use of cannabis products among people with (previous) hyperkinetic behavior. There does not appear to be a significant difference regarding opiates, cocaine, amphetamines, sedatives, and hallucinogens.168
Although the co-occurrence of hyperkinetic and socially disruptive behavior is associated with early-onset use of illicit drugs, statistically, only earlier and more frequent nicotine use has been demonstrated.168
Adults with ADHD and substance use disorders began using substances at a younger age and used the following substances:169

  • Most common: alcohol, cannabis, methamphetamine, tramadol
  • less common: methylphenidate, methadone, ecstasy, morphine, hypnotics

Chronic abuse of dopaminergic drugs (cocaine, amphetamines) leads to a long-lasting downregulation of dopamine levels. Withdrawal symptoms then correspond to those of ADHD. 170 Against this backdrop, the question arises as to whether ADHD medications (stimulants)—which are known not to produce any intoxicating effects—might be helpful during withdrawal from dopaminergic drugs.
People with ADHD and comorbid cocaine addiction showed a significant reduction in addictive behavior when treated with stimulants.125

Common symptoms of addiction/substance abuse and ADHD:53

  • Impulsivity
  • (internal) restlessness, motor hyperactivity
  • Difficulty concentrating
  • excessive talkativeness (logorrhea, polyphasia)

ADHD symptoms that are atypical for addiction or substance abuse:

  • Racing thoughts, ruminating
  • Attention problems
  • Dysphoria due to inactivity
  • Mood swings

Symptoms of addiction/substance abuse that are atypical for ADHD:

  • Substance Abuse:
    • excessive consumption of a substance, even when there are serious Consequences
  • Addiction:
    • excessive use leading to drug dependence
    • very hard to stop

9. Restless Legs Syndrome (RLS, akathisia) - 11 to 44% (vs. 2.6 to 15.3%)

A meta-analysis found RLS in 11 to 42.9% of children with ADHD and in 20–33.0% of adults with ADHD. In the general population, RLS was found in 2.6 to 15.3% of people.171 Another meta-analysis (k = 9) found a prevalence of 11 to 54% among children with ADHD.172
A study of people with ADHD (ages 6 to 16) found that 33.3% had RLS.173 Other sources cite a rate of 44%.174 A smaller study of adults with ADHD found that 20% had RLS, and that comorbid RLS exacerbated ADHD symptoms.175
Kooij estimates that 30% to 40% of people with ADHD also have RLS.40
One study found that 10% of people with ADHD had a disorder of periodic limb movements (PLMS) (more than 5 per hour).176 Another study found a PLMS index of more than 5 per hour in 66% of all children with ADHD, which is a marker for RLS, while none of the children without ADHD had an elevated PLMS index.177 A meta-analysis found no evidence of more frequent PLMS in ADHD.178
Among adult psychiatric inpatients with ADHD, 25.5% had RLS.71
A large cohort study found a strong correlation between restless legs syndrome and ADHD.179

Up to 26% of people with RLS also have ADHD.174

Regardless of ADHD, RLS occurs in about 2% of all children and adolescents, with 0.5 to 1% experiencing moderate to severe symptoms. Among adults, it affects 5 to 10%. For 25% of people with ADHD, the disorder begins between the ages of 10 and 20.180 Other sources cite a prevalence of RLS of up to 8%.181
In 70% of cases, people with ADHD are also affected.

No genetic link between RLS and ADHD has been established to date. It is conceivable that the BTBD9 gene, which is associated with iron stores, plays a role.
69.4% of children and adolescents with RLS have sleep disturbances (vs. 39.6% of those without the condition), and 80.6% have a history of “growing pains” (vs. 63.2% of those without the condition).181

9.1. Iron Deficiency in RLS and ADHD

There is growing evidence that iron deficiency (serum ferritin levels < 12 ng/ml) underlies common pathophysiological mechanisms in patients with RLS and patients with ADHD-HI.181
Iron is a cofactor for tyrosine hydroxylase, an enzyme essential for dopamine synthesis. Both ADHD and RLS are frequently associated with reduced iron levels. Lower serum ferritin levels in people with ADHD correlate with more severe ADHD-HI symptoms. Children with ADHD and RLS had lower ferritin levels than children with ADHD without RLS.182183 184 However, other studies found no reduced serum ferritin levels in ADHD.185186
In RLS, the severity correlates more strongly with reduced S-ferritin levels.187188 particularly in children.189 It is possible that impaired transport of iron from the serum into the cerebrospinal fluid and from the cerebrospinal fluid into dopaminergic cells leads to reduced iron concentrations in the cerebrum.190 Adults with RLS exhibit low iron levels in the cerebrum.191
Children with ADHD and a predisposition to RLS appear to constitute a subgroup at particular risk for severe ADHD-HI symptoms, and iron deficiency may contribute to the severity of ADHD symptoms.182
An RC study found that children with ADHD and low ferritin levels experienced an improvement in ADHD symptoms when given iron (80 mg/day).192

9.2. Adenosine in RLS and ADHD

Restless legs syndrome may result from downregulation of adenosine A1 receptors as a consequence of iron deficiency.193
Adenosine is closely linked to dopamine. Adenosine receptors are found throughout the brain near dopamine receptors and sometimes form receptor heteromers with them. Adenosine may also be involved in ADHD, although this is likely due to an excessive adenosine effect at adenosine A2A receptors. Adenosine inhibits dopamine; therefore, adenosine antagonists such as caffeine (coffee, cola, black tea) and theobromine (cocoa) increase dopamine levels.
For more on this, see the article => Adenosine.

9.3. Treatment of RLS in ADHD

The problem with the comorbidity of restless legs syndrome and ADHD is that ADHD medications (even though they are dopaminergic) are not effective against RLS, and RLS medications such as L-dopa (even though they are also dopaminergic) are not effective against ADHD.194181195
Long-term treatment with L-dopa often leads to a worsening of RLS symptoms.
Concomitant administration of L-dopa and stimulants may cause increased side effects.

A case report documented a good response to the dopamine agonist ropinirole in a 6-year-old boy with ADHD and RLS who was also a non-responder to MPH, with regard to both ADHD and RLS.196

10. Cognitive Disengagement Syndrome, CDS (SCT) - 41.3%

CDS (formerly known as Sluggish Cognitive Tempo, SCT) was found in 41.3% of people with ADHD in an Iranian study.197

11. Specific Learning Disabilities - up to 40%

Source6

A study found specific learning disabilities in 6.6% of children between the ages of 7 and 11. Reading difficulties were found in 4%, math difficulties in 3.6%, and difficulties with written expression in 1.8%. Approximately 63% of children with specific learning disabilities had one or more comorbid diagnoses, with ADHD being the most common comorbidity, found in 54.9% of cases. Boys were affected more frequently.198

11.1. Reading difficulties, dyslexia—8 to 40% (vs. 5.6%)

A distinction must be made:

  • Reading and Spelling Difficulties (LRS): an acquired, temporary difficulty, usually caused by external circumstances
  • Dyslexia: a genetically caused disorder affecting reading and writing that cannot be overcome through normal practice
  • Dyslexia (reading difficulty): Impaired ability to read and understand words or texts, despite normal vision and hearing. Learning disability.
  • Alexia: complete loss of the ability to read

8–39%199200 , 25–40%86, 40%104

Dyslexia and ADHD share significant genetic overlap.201202 There is no evidence of a causal relationship between the two.202
A study found only weak evidence of overlapping neurophysiological changes in ADHD and dyslexia.203

According to teacher assessments, 6-year-olds with reading difficulties are about four times as likely to have ADHD (21.0% versus 5.6%), and according to parent assessments, they are about twice as likely to have ADHD (30.5% versus 17.8%) as children without reading difficulties.204
There is evidence that reading difficulties associated with ADHD are associated with different patterns of brain connectivity than reading difficulties not associated with ADHD.205

65 to 70% of all children with reading and spelling difficulties are said to have functional binocular vision disorders:206

  • Oculomotor dysfunction (OMD) (9%)
    • Impaired fixation
    • Impaired follow-through movements
    • Impaired horizontal eye saccades
  • Dysfunctional binocular vision (DBV) (16%)
    • Heterophoria
    • Suppression
    • Convergence insufficiency
    • Accommodative dysfunction
    • Insufficient fusion
    • Insufficient stereopsis
  • DBS and OMD (51%)
  • Neither DMS nor OMD (24%)

A study of 1,260 children in Pakistan found that 21.2% had dyslexia and 7.6% had ADHD:207

  • 192 cases of dyslexia (15.2%)
  • 76 cases of dyslexia and ADHD (6.0%)
  • in 20 cases of ADHD (1.6%)

11.2. Spelling difficulties (agraphia, dysgraphia) - 12 to 40%

12–27%5, 25–40%86, 40%104
This is also true for adults with ADHD.208

11.3. Math Difficulties (Dyscalculia) 12–27%

12–27%5
A meta-analysis found that reading difficulties correlate more strongly with math difficulties than with ADHD.209
This is also true for adults with ADHD.208
ADHD and dyscalculia appear to share common genetic causes. No evidence of a causal relationship between the two was found.202

Mathematical performance is thought to correlate less with ADHD itself than with executive function problems associated with ADHD.210 In individuals with ADHD, math problems correlated with working memory problems, but not with anxiety.211

11.4. Face Recognition Disorder (Prosopagnosia)

It is unclear whether face recognition difficulties are more common in people with ADHD. Some sources suggest they are212, while others suggest they are not213.

11.5. Difficulty Remembering Names

Difficulty remembering names is said to be more common in people with ADHD.212

11.6. Speech Disorders

Speech disorders are said to be more common in ADHD.6

11.7. Difficulty Distinguishing Right from Left

Difficulty distinguishing right from left correlates with ADHD.214
The overall prevalence of right-left confusion among medical students was 14.7%.

12. Developmental disorder—up to 37.4%

Developmental disability (Total adults with ADHD: 24.7%; women 25.6%, men 23.8%; ADHD-I 22.6%, ADHD-C 25.6%, ADHD-HI 37.5%)65

12.1. Specific developmental disorders - 37.4% (vs. 13.4%)

  • among children with ADHD: 37.4%41
  • Among those not affected: 13.4%41
    = three times the risk

12.2. Specific developmental disorders affecting academic skills - 23% (vs. 2.8%)

  • among children with ADHD: 23.0%41
  • Among those not affected: 2.8%41
    = an 8-fold increase in risk

13. Bipolar Disorders - 4.5 to 35.5% (vs. 0.2 to 3.6%)

Bipolar disorder was diagnosed in

  • 14.29% (men: 9.95%; women: 18.95%) of adults with ADHD, compared to 0.72% (men: 0.53%; women: 0.91%) of people without ADHD (large Swedish cohort study)55
  • 10.9% (men: 8.9%; women: 12.9%) of adults with ADHD, compared with 1.3% (men: 1.1%; women: 1.6%) of people without ADHD.56
  • 6%42; (Total adults with ADHD: 6.4%; women 8.3%, men 4.7%; ADHD-I 5.1%, ADHD-C 8.0%, ADHD-HI 10.0%)65
  • 5.1% of adult psychiatric inpatients with ADHD71
  • 4.7% (across the entire age range)27

Among the 2.4 million people studied, 9,250 cases of bipolar disorders were observed. If ADHD was present beforehand, the lifetime risk of bipolar disorder increased 12-fold; if both ADHD and an anxiety disorder were present beforehand, the risk increased 30-fold compared to individuals without ADHD or an anxiety disorder.215

People with bipolar disorder have an ADHD prevalence of:

  • 60% (meta-analysis of twenty studies involving N = 2,722 PBD patients (mean age = 12.2 years))216
  • 27% among people with ADHD who are in a manic phase217
  • 25% (n = 703 adults with bipolar disorder), with men and people with bipolar I disorder more frequently having comorbid ADHD.218
  • Increased by a factor of 3.06219

A meta-analysis found bipolar disorder in people with ADHD and in those without ADHD:67

  • in the general population at
    • 4.48% to 35.5% of people with ADHD vs. 0.2% to 3.6% of people without ADHD
  • in clinical cases involving
    • 7.4% to 80% of people with ADHD vs. 2% to 19.5% of people without ADHD

A study found evidence of overlap in the genetic causes of bipolar disorder and ADHD, particularly in early-onset bipolar disorder (under age 21);220 another study also found genetic overlap between bipolar disorder and ADHD.221

14. Personality Disorders (in Adults) - 11.5% to 33.2% (vs. 0.9% to 1.4%)

Personality disorders are generally not yet diagnosed in children.

The following prevalence rates were found among adults:

  • 11.5% (men: 9.1%; women: 13.6%) of adults with ADHD, compared with 1.4% (men: 1.1%; women: 1.7%) of people without ADHD.56
  • 33.2% among adults with ADHD41 to 80.3% among adult outpatients at clinics with ADHD222
  • Among those not affected: 0.6%41
    = 50 times the risk

A meta-analysis found personality disorders:112

  • in the general population at
    • 0.31% to 33.8% of people with ADHD vs. 0% to 3.9% of people without ADHD
  • in clinical cases involving
    • 21.9% to 65.95% of people with ADHD vs. 6.6% to 34.4% of those without ADHD

14.1. Antisocial PS - 18% (vs. 2 to 3.5%)

A study found antisocial personality disorder in 18% of people with ADHD-HI who exhibited hyperactivity, compared to 2% of people without the condition.223.
Other sources cite 37.1%22489 .
A study found that 18.9% of adults with ADHD had exhibited antisocial behavior at least once in their lives, compared with 3.5% of people with ADHD.64

Of 30 people with ADHD-HI in prison, 96% also had antisocial personality disorder.
In contrast, no antisocial personality disorder was diagnosed in 20 people with ADHD-HI who were not in prison and 18 people without ADHD.Interestingly, amphetamines are the most commonly used drugs among prison inmates with ADHD-HI.131 As is well known, amphetamines are a highly effective medication for ADHD.

Among offenders convicted of domestic violence who had ADHD, ADHD treatment reduced domestic violence to a far greater extent than interventions specifically aimed at addressing domestic violence.225

14.2. Borderline Personality Disorder / Emotionally Unstable Personality Disorder - 18 to 33% (vs. 1 to 5%)

It is estimated that 18.3% of adults with ADHD also have BPD.226
A population-based study found that 33.7% of people with ADHD also had borderline personality disorder (BPD) (compared with 5.2% in the general population).64
A Swedish cohort study found that people with ADHD had a 19.4-fold increased risk of comorbid borderline personality disorder.227 3.9% of the more than 2 million participants had a diagnosis of ADHD (3.0% of women, 4.8% of men), and 0.5% had BPD (0.8% of women, 0.1% of men). People who had relatives diagnosed with ADHD also had an increased risk of BPD:

  • Identical twins: N = 9,130, OR = 11.2 (Among 9,130 twins, the risk of BPD was 11.2 times higher if the other twin had ADHD)
  • Fraternal twins: N = 17,350, OR = 1.0
  • Full siblings: N = 2,211,396, OR = 2.4
  • Maternal half-siblings: N = 332,486, OR = 1.4
  • Half-siblings on the father’s side: N = 331,080; OR = 1.5
  • Cousins whose parents are full siblings: n = 6,456,848; OR = 1.5
  • First cousins on the mother’s side: N = 472,212; OR = 1.3
  • Cousins’ paternal parents’ half-siblings: N = 466,836; OR = 1.2

The risk of a BPD diagnosis when people with ADHD or full siblings had ADHD was:227

  • 19.1 times higher in women (OR = 19.1)
  • 21.8 times higher in men (OR = 21.8)

People with ADHD who had the condition as children were 14% more likely to be diagnosed with BPD later.228

BPS among people with ADHD: 35.7%22489

Among adult psychiatric inpatients with ADHD: 30.6%71

People with BPS have an ADHD prevalence of 30 to 60 percent.229230231232

For the differential diagnosis of ADHD and borderline personality disorder, see Emotionally Unstable Personality Disorder / Borderline In the article Differential Diagnosis of ADHD in the chapter at Diagnosis.

14.3. Anxious PS - 10.6% (vs. 2.1%)

A study found that 10.6% of adults with ADHD had experienced avoidant PS at least once in their lives, compared with 2.1% of people without ADHD.64
Among adult psychiatric inpatients with ADHD: 31.6%71

14.4. Insecure PS

27.1%22489

14.5. Compulsive PS - 19.3 (vs. 7.8%)

A study found that 19.3% of adults with ADHD had experienced compulsive PS at least once in their lives, compared with 7.8% of people without ADHD.64
40.7%22489

Among adult psychiatric inpatients with ADHD: 10.2%71

14.6. Combined PS

Among adult psychiatric inpatients with ADHD: 25.5%71

14.7. Paranoid PS - 14.8% (vs. 4.1%)

20.0%22489
A study found that 14.8% of adults with ADHD had experienced paranoid delusions at least once in their lives, compared with 4.1% of people without ADHD.64

14.8. Dependent PS - 3.1% (vs. 0.4%)

15.7%22489
A study found that 3.1% of adults with ADHD had experienced substance dependence at least once in their lives, compared with 0.4% of people without ADHD.64

Among adult psychiatric inpatients with ADHD: 18.4%71

14.9. Narcissistic PS

15.7%22489
A study found that 25.2% of adults with ADHD had experienced narcissistic personality traits at least once in their lives, compared with 5.7% of people without ADHD.64

14.10. Histrionic PS - 10.7% (vs. 1.6%)

14.3%22489
One study found that 10.7% of adults with ADHD had experienced histrionic personality disorder at least once in their lives, compared with 1.6% of people without ADHD.64

14.11. Schizotype PS - 22.4% (vs. 3.5%)

8.6%89
A study found that 22.4% of adults with ADHD had schizotypal personality disorder at least once in their lives, compared with 3.5% of people without ADHD.64

Former terms: borderline schizophrenia, latent schizophrenic reaction, pseudoneurotic schizophrenia

14.12. Schizoid PS - 9.2% (vs. 2.9%)

6.4%89
One study found that 9.2% of adults with ADHD had experienced schizoid personality traits at least once in their lives, compared with 2.9% of people without ADHD.64

15. Premenstrual Dysphoric Disorder (PMDD) - 31.4% (vs. 9.8%)

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS). It occurs in the days leading up to menstruation and subsides once menstruation begins. Symptoms include

  • Mood swings
  • Irritability
  • Feelings of anxiety
  • Difficulty concentrating
  • depressive moods.

PMDD was reported by 31.4% of women with a self-reported ADHD diagnosis and by 41.1% of women who screened positive for ADHD using the ASRS, compared with 9.8% of women without ADHD.233

16. Tic disorders 30% (vs. 5%)

Source621

Approximately 30% of all patients with ADHD have tics or Tourette syndrome, while about half of all patients with a tic disorder or Tourette syndrome also have ADHD.234
The prevalence of tic disorders in the general population is approximately 5%.235

17. Post-Traumatic Stress Disorder (PTSD) - 11.9% to 28% (vs. 3.3% to 6%)

  • The prevalence of PTSD in the general population is
    • 3.3%66
    • 6% lifetime prevalence64

The following prevalence rates of comorbid PTSD were found among people with ADHD:

Meta-analyses:

  • 28 to 36% among adults with ADHD (meta-analysis, k = 21)236

Studies:

  • 0.7% of adults with ADHD overall65
    • 0.7% women
    • 0.7% men
    • 0.9% ADHD-I
    • 0.0% ADHD-C
    • 2.5% ADHD-HI
  • 11.9%, representing an increase of about 3.6 times.66
  • 22% of adults with ADHD64
  • 26.5% among adult psychiatric inpatients with ADHD71
  • The comorbidity of ADHD and PTSD was 32% more common in women than in men, but this was true only for adults (meta-analysis, k = 13, N = 13,585)237

PTSD is associated with a significantly increased risk of ADHD (up to +153%)

  • 2.53-fold increased risk of ADHD (+153%) among war veterans with a history of PTSD238
  • 2.19-fold increased risk of ADHD (+119%) among war veterans with existing PTSD238

18. Impulse Control Disorder (ICD) - 19.6% (vs. 6.1%)

  • The prevalence of impulse control disorders (ICD) in the general population is 6.1%. Among people with ADHD, the prevalence is 19.6%, which is approximately 3.2 times higher.66
  • Total adults: 2.6%; women: 2.9%, men: 3.7%; ADHD-I: 1.2%, ADHD-C: 5.0%, ADHD-HI: 12.5%65

Impulse control disorders are characterized by a recurring, irresistible urge to engage in certain behaviors that harm the person with ADHD or others and are often associated with feelings of guilt or shame, even though they provide short-term relief.

  • Pathological Gambling (Gambling Addiction)
  • Kleptomania (stealing)
  • Pyromania (arson)

19. Adjustment Disorders - 18.9% (vs. 3%)

Adjustment disorders are described as reactions to a single or ongoing stressful life event.
Types of adjustment disorders include:

  • Brief depressive reaction
  • Prolonged depressive reaction (up to 2 years)
  • Mixed anxiety and depressive reaction
  • with a predominant impairment of other emotions
  • with predominantly impaired social disorder
  • with a combination of emotional and social disorders
  • with other predominantly mentioned symptoms

Prevalence among individuals with ADHD:

  • Among people with ADHD: 18.9%41
  • for those not affected: 3.0%41
    = a 6-fold increase in risk

20. Intellectual disability - 1.4% to 13%

I was diagnosed with an intellectual disability along with ADHD

  • at 13% 104
  • 1.4% for adults overall; 1.8% for women, 1.0% for men; ADHD-I 1.2%, ADHD-C 1.0%, ADHD-HI 5.0%65

Among the 47,330 people with ADHD, the following were found:239

  • 24.5% ASS
  • 15.6% epilepsy
  • 11.8% ADHD and learning disabilities
  • 7.6% cerebral palsy
  • 6.4% Down syndrome
  • 1.0% other congenital syndromes

21. Eating Disorders – Loss of Control Eating Syndrome (LOC-ES) – 7.5 to 11.4% (vs. 1.4%)

A 12-fold increased risk among people with ADHD-HI.240241

A cohort study of Iranian children and adolescents found an increased prevalence of ADHD—7.5%—among people with eating disorders.242

A very large study found that ADHD is associated with an 18.3-fold increased risk of bulimia or anorexia.243

Appetite disorders in adults with ADHD: 21%

Disordered eating was 40% more common among adolescents with ADHD.244

1.4% diagnostic prevalence of eating disorders among n = 221,714 people with ADHD (average age 25.1 years) 19

22. Psychoses - 8.8% (vs. 3%)

A study found that 8.8% of adults with ADHD had experienced psychosis at least once in their lives, compared with 3% of people without ADHD.64

23. Epilepsy - 3.4% (vs. 0.5 to 1%)

A meta-analysis of 63 studies involving N = 1,073,188 participants from 17 countries found that:245
People with epilepsy had an ADHD prevalence of 22.3% (12.7% for ADHD-I).
People with ADHD had an epilepsy prevalence of 3.4%.
The prevalence of ADHD is significantly higher in patients with drug-resistant epilepsy.246

A study found that 35% of adults with epilepsy also had ADHD.247
Epilepsy and ADHD have a genetic correlation (rg = 0.18), which was even stronger in cases of focal epilepsy (rg = 0.23).248

Among adults with psychogenic non-epileptic seizures (PNES), 63.6% were found to have ADHD, while among adults with epileptic seizures (ES), 27.8% were found to have ADHD.249

Some medications used to treat seizures can cause or worsen ADHD symptoms as a side effect, while some ADHD medications can increase the risk of seizures.250

The prevalence of epilepsy in the general population is 0.5 to 1%.
44.1% of people with ADHD have at least one other mental health diagnosis at some point in their lives.248

24. Schizophrenia - 3.4% (vs. 0.8%)

Prevalence of Schizophrenia in ADHD:

  • 4.59-fold increased risk of schizophrenia in individuals with ADHD (meta-analysis, k = 12, N = 1.85 million)251
    • 5.09 times the risk of a psychotic disorder
  • A 4.74-fold increased risk of schizophrenia in individuals diagnosed with ADHD in childhood252
    • 3.5% of the people with schizophrenia studied also had ADHD F 90.0, i.e., ADHD with hyperactivity, without ADHD-I (which, however, does not seem to fit in any way with the other figures mentioned in this section)
  • A Norwegian cohort study found schizophrenia in 3.4% (men: 4.2%; women: 2.5%) of adults with ADHD, compared with 0.8% (men: 0.9%; women: 0.6%) of those without ADHD.56
  • Another study found a prevalence of schizophrenia among individuals with ADHD of 0.9% across the entire age range27
  • People with ADHD and an additional comorbidity had a 2.14-fold increased risk of schizophrenia compared to people with ADHD without any other comorbidities253. The risk of schizophrenia continued to rise with the number of comorbidities. In particular, ASD, intellectual disability, tic disorder, depression, and bipolar disorder showed the strongest correlation. 73.8% of people with ADHD who initially had no psychiatric comorbidities exhibited other psychiatric disorders prior to the onset of schizophrenia.

The prevalence of ADHD is significantly higher among people with schizophrenia.

  • Children and adolescents with schizophrenia
    • 17% to 57% also have ADHD (meta-analysis, k = 5)254
  • Adults with schizophrenia
    • 10% to 47% also have ADHD (meta-analysis, k = 5)254
  • 47% reported having ADHD as a child or as an adult255
  • 23% reported having ADHD during childhood and adulthood255

1.1% diagnostic prevalence of schizophrenia spectrum disorders among n = 221,714 people with ADHD (average age 25.1 years) 19

25. Obsessive-Compulsive Disorder - 1.9 to 2.4%

Obsessive-compulsive disorder is more commonly comorbid with ADHD in adults.6

  • Total number of adults with ADHD: 1.9%; women 1.4%, men 2.4%; ADHD-I 0.9%, ADHD-C 1.5%, ADHD-HI 12.5%65

  • 2.4% across the entire age range27

  • A large study found that family members of people with ADHD had a 2.19-fold higher prevalence of ADHD.256

  • Of 70 adults with ADHD, 8.7% had experienced an obsessive-compulsive disorder at some point in their lives, compared with 5.7% of the 70 adults without ADHD.54

26. Migraine

Source21

27. Obesity

A 2.1-fold increased risk for people with ADHD.257

A study found that genetic variants associated with obesity may causally increase the risk of ADHD.150
For treatment options, see section 4.5 below.

28. Socialization Disorder

Source6

29. Disorder of Sexual Development

Source6

  • Earlier onset of sexual activity
    • for children with ADHD: 15 years258
    • for those not affected: 16 years258
  • More sexual partners
    • for people with ADHD: 18.6258
    • for those not affected: 6.5258
  • Less time with a partner258
  • Higher rate of contraception258
  • High rate of unwanted pregnancies
    • among children with ADHD: 38%258
    • Among those not affected: 4%258
      = 19.5 times the risk
  • Teenage pregnancies: 5.5 times as many259
    • Teenage pregnancies among mothers with ADHD: 15.3%
    • Teenage pregnancies among mothers without ADHD: 2.8%
  • Increase in the number of births (42:1)258
    = 42 times the risk
  • Higher risk of sexually transmitted diseases
    • Among people with ADHD: 16%258
    • Among those not affected: 4%258
      = four times the risk

30. Narcolepsy

A meta-analysis found that approximately 33% of all people with narcolepsy also have ADHD.38

31. Hoarding Disorder

Hoarding disorder is characterized by a strong urge to collect useless objects, leading to a tendency to clutter one’s living environment. A strong association with ADHD is being discussed.260 An overview of the literature can be found in Kuwano et al.261 They found a comorbidity rate of ADHD among people with hoarding disorder of 26.7%.

In 71.6% of people with ADHD and comorbid hoarding, MPH improved the hoarding.262 In 5%, it remained unchanged, and 23.4% showed a slight worsening.

32. Attachment Disorders

Source6

A study found that genetic variants associated with increased social interaction serve as a protective factor against ADHD.150

33. Enuresis (Bedwetting)

Source6
Enuresis in children increased the risk of comorbid ADHD by a factor of 2.15 (OR 3.15).263

34. Encopresis (fecal incontinence)

Source6

35. Suicidal tendencies—2.4 to 6.7 times higher

A meta-analysis of 57 studies found a correlation between ADHD and264

  • Suicide attempts (OR 2.37)
  • Suicidal thoughts (OR 3.53)
  • Suicidal thoughts (OR 4.54)
  • a suicide (OR 6.69).

According to this, suicide is between 2.37 and 6.69 times more common among people with ADHD than among those without the condition.

Another study found an increased risk of suicide among children and adolescents with ADHD (OR 1.1); however, this risk was mediated by comorbid depression, irritability, and anxiety, not by ADHD itself.265

36. Fibromyalgia - 4-part series

A study found that the prevalence of ADHD was four times higher among people with fibromyalgia, without specifying the prevalence of fibromyalgia among people with ADHD.266

37. Dopamine Transporter Deficiency Syndrome (DTDS)

Dopamine Transporter Deficiency Syndrome (DTDS) is also known as infantile parkinsonism-dystonia.
Prevalence: very rare. To date, 60 people with ADHD have been reported.267

DTDS is an inherited genetic disorder characterized by a dysfunctional dopamine transporter.
Classic early-onset DTDS occurs within the first 6 months of life. In rare cases, late-onset DTDS may not become apparent until adolescence or even adulthood.267268

In one study, all people with early-onset (childhood or adolescent) parkinsonism showed severely impaired DAT function (homozygous for a dysfunctional variant or two heterozygous dysfunctional DAT variants). The more severe the DAT dysfunction, the earlier Parkinsonism developed. Most people with ADHD carried previously unknown de novo variants. The dysfunctions were diverse: reduced dopamine binding affinity, reduced cell surface transporter activity, loss of posttranslational glycosylation of the dopamine transporter, and failure of amphetamine-mediated dopamine efflux.268 The following DTDS-DAT variants were identified:

  • Homozygous
    • c.941C>T → Ala314Val (3 out of 8 people with ADHD)
    • c.1269 + 1G>A → unknown (2 out of 8 people with ADHD); another study also reported this variant269
    • c.1408_1409delinsAG → Tyr470Ser (1 of 8 people with ADHD)
  • Combination of two dysfunctional DAT variants:
    • 1 in 8 people with ADHD:
      • c.287-5_287-2delinsAAC → unknown
      • c.1156G>A –> Gly386Arg
    • 1 in 8 people with ADHD:
      • c.254G>T –> Arg85Leu
      • c.1333C>T –> Arg445Cys

Classic early-onset DTDS:267

  • Onset within the first 6 months (infants)
  • nonspecific symptoms
    • Irritability
    • Difficulties with breastfeeding
    • axial hypotension
    • delayed motor development
  • followed by a hyperkinetic movement disorder
    • with characteristics of
      • Chorea
      • Dystonia
      • Ballism
      • orolingual dyskinesia
  • Over time
    • Parkinsonism-Dystonia Complex
      • Bradykinesia, progressing to akinesia
      • dystonic posture
      • distal tremor
    • Rigidity
    • reduced facial expressions
    • severe motor delay due to impaired voluntary movements
    • Episodic dystonic status
    • Worsening of dystonia
    • secondary orthopedic, gastrointestinal, and respiratory complications
  • intelligence is generally well preserved, with good cognitive development

Atypical late-onset DTDS:267

  • Onset ranging from childhood through adulthood (fourth decade of life)
    • in 5 of the 60 people with ADHD
  • Infancy and early childhood:
    • Normal psychomotor development
  • Childhood
    • ADHD or individual ADHD symptoms
  • late-onset
    • Parkinsonism-dystonia with
      • Tremor
      • progressive bradykinesia
      • variable tone
      • dystonic posture

Diagnostics:267

Cerebrospinal fluid (CSF) almost always shows

  • HVA: The 5-HIAA ratio in SLC6A3-related DTDS is >4.0 (5.0–13.0) (normal range 1.0–4.0).
    • elevated levels of homovanillic acid (HVA, a metabolite derived from dopamine)
    • Normal levels of 5-hydroxyindoleacetic acid (5-HIAA, a metabolite derived from serotonin)
  • Pterin: normal
  • SPECT imaging using the ligand ioflupane (DaTSCAN):
    • highly abnormal results with absent or reduced tracer uptake in the basal ganglia
  • Genetic analysis
    • Presence of a heterozygous, dominant-negative pathogenic SLC6A3 variant known to cause autosomal dominant DTDS
      • e.g., p.Lys619Asn

38. Stuttering

A study reports a 50% prevalence of ADHD among children and adolescents who stutter.270

39. Body-Focused Repetitive Behavioral Disorders (BFRDB, BFRB)

Body-focused repetitive behavior disorders (BFRDB) are related to impulse control disorders. Some of them are sometimes considered impulse control disorders, but distinguishing between the two is difficult.
BFRBDs are characterized by an irresistible urge, often accompanied by tension that is relieved by the act itself, which bears similarities to ICDs. While ICDs have traditionally been classified as distinct Disorders, BFRBDs are now classified in the ICD-11 within the spectrum of obsessive-compulsive disorders and related disorders, albeit in a separate subcategory, which underscores their complex nature.

The BFRDB includes, among other things:

  • Bruxism (teeth grinding)
  • Crepitus (cracking of the finger joints)
  • Dermatophagia (skin biting)
  • Thumb-sucking
  • Lip-biting keratosis (lip biting)
  • Morsicatio buccarum (cheek biting)
  • Onychophagia (nail-biting)
  • Onychotillomania (nail-biting)
  • Rhinotillexomania (nose-picking)
  • Trichophagia (eating hair)
  • Trichotillomania (hair pulling)

39.1. Trichotillomania

Trichotillomania (compulsive hair pulling) was associated with a 5.34-fold increased risk of ADHD, as well as increased risks for271

  • Obsessive-compulsive disorder: 18.3 times
  • Borderline personality disorder: 15 times
  • Anxiety disorders: 10.2 times
  • Alcohol abuse: 6.13 times
  • Depression: 5.89 times
  • Vitamin D deficiency: 4.2 times

39.2. Nail-biting

A study examined 450 children. 14% of them bit their nails. Among these were:272

  • ADHD in 74.6%
  • Oppositional defiant behavior in 36%
  • Separation anxiety in 20.6%
  • Bedwetting at 15.6%
  • Tic disorders in 12.7%
  • Obsessive-compulsive disorder in 11.1%
  • intellectual disability in 9.5% of cases
  • severe depressive disorders in 6.7%
  • Pervasive developmental disorders in 3.2%

40. Mental Health Disorders Among Relatives of People with ADHD - 6.8 Times More Common

An analysis of the entire Taiwanese population in 2010 examined 220,966 parents of children with ADHD-HI (according to ICD-9, which did not recognize ADHD-I), 174,460 siblings of children with ADHD-HI, and 5,875 children of parents with ADHD-HI. Among these relatives of people with ADHD-HI, the risk of severe psychiatric disorders was significantly higher compared to matched control subjects who had no relatives with ADHD-HI:273

  • ADHD-HI: 6.87 times the risk
  • Autism spectrum disorder: 4.14 times the risk
  • bipolar disorders: 2.21 times the risk
  • Severe depressive disorders: 2.08-fold risk
  • Schizophrenia: 1.69 times the risk

This can be interpreted as evidence of shared genetic causes. However, it is also theoretically conceivable that this could be explained by the immunological Consequences of (primarily viral) infections (which are more frequently transmitted among close contacts). See the chapter “ ” ⇒ The Immune System and Behavior.
Similarly, people who are close to one another are likely to share similar external life circumstances, as well as similar dysfunctional behavior patterns and stressful experiences. These mechanisms can reinforce one another.


  1. Schmidt, Waldmann, Petermann, Brähler (2010): Wie stark sind Erwachsene mit ADHS und komorbiden Störungen in ihrer gesundheitsbezogenen Lebensqualität beeinträchtigt? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 58, 9–21, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229

  2. Merrill RM, Merrill AW, Madsen M (2022): Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury. Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. PMID: 36277995; PMCID: PMC9586798.

  3. Okada T, Sotodate T, Ogasawara-Shimizu M, Nishigaki N (2024): Psychiatric comorbidities of attention deficit/hyperactivity disorder in Japan: a nationwide population-based study. Front Psychiatry. 2024 Oct 24;15:1359872. doi: 10.3389/fpsyt.2024.1359872. PMID: 39512898; PMCID: PMC11541049.

  4. nach Hudziak und Todd, 2001, zitiert aus Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 16

  5. Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071: Kommentare zu Romanos & Jans (2014). ADHS – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071

  6. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 53, ohne %-Angabe

  7. Ohnishi T, Kobayashi H, Yajima T, Koyama T, Noguchi K (2019): Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. Innov Clin Neurosci. 2019 Sep 1;16(9-10):11-16. PMID: 32082943; PMCID: PMC7009330. n = 575

  8. Hollingdale, Woodhouse, Young, Fridman, Mandy (2019): Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review. Psychol Med. 2019 Sep 18:1-14. doi: 10.1017/S0033291719002368.} METASTUDY}{{Joshi, Wilens (2022): Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder. Child Adolesc Psychiatr Clin N Am. 2022 Jul;31(3):449-468. doi: 10.1016/j.chc.2022.03.012. PMID: 35697395. REVIEW

  9. Fan HC, Kuo FC, Lee JY, Chang YM, Chiang KT, Chiang KL (2025): Effect of Parental-Child Age Gaps and Skipped-Generation Families on Comorbidities Related to Attention Deficit Hyperactivity Disorder: A Population-Based Case-Control Study. Children (Basel). 2025 Aug 26;12(9):1123. doi: 10.3390/children12091123. PMID: 41006988; PMCID: PMC12468086. N = 474-978, n = 79.163

  10. Russell G, Rodgers LR, Ukoumunne OC, Ford T (2014): Prevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort Study. J Autism Dev Disord. 2014 Jan;44(1):31-40. doi: 10.1007/s10803-013-1849-0. PMID: 23719853.

  11. Brancati GE, De Rosa U, Magnesa A, Cocciaro I, Costagli E, Iriti A, Rimoldi B, Vedovelli M, Medda P, Schiavi E, Perugi G (2025): Autism spectrum traits in adults with attention-deficit/hyperactivity disorder (ADHD): a hidden multifaceted phenotype marked by affective comorbidity, emotional dysregulation, and chronobiological disturbances. Eur Arch Psychiatry Clin Neurosci. 2025 Sep 17. doi: 10.1007/s00406-025-02114-9. PMID: 40960503.

  12. Jiang Z, Li G, Zeng S, Li J, Li Y, Lin J, Fan Q (2024): Causal Relationship between Attention-Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Two-Sample Mendelian Randomization. Br J Hosp Med (Lond). 2024 Dec 30;85(12):1-16. doi: 10.12968/hmed.2024.0588. Epub 2024 Dec 27. PMID: 39831504.

  13. Grzadzinski R, Di Martino A, Brady E, Mairena MA, O’Neale M, Petkova E, Lord C, Castellanos FX (2011): Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD? J Autism Dev Disord. 2011 Sep;41(9):1178-91. doi: 10.1007/s10803-010-1135-3. PMID: 21108041; PMCID: PMC3123401.

  14. Joshi G, DiSalvo M, Faraone SV, Wozniak J, Fried R, Galdo M, Belser A, Hoskova B, Dallenbach NT, De Leon MF, Biederman J (2020): Predictive utility of autistic traits in youth with ADHD: a controlled 10-year longitudinal follow-up study. Eur Child Adolesc Psychiatry. 2020 Jun;29(6):791-801. doi: 10.1007/s00787-019-01384-8. PMID: 31468149.

  15. Biederman J, Petty CR, Fried R, Wozniak J, Micco JA, Henin A, Doyle R, Joshi G, Galdo M, Kotarski M, Caruso J, Yorks D, Faraone SV (2010): Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study. J Dev Behav Pediatr. 2010 Jul-Aug;31(6):485-90. doi: 10.1097/DBP.0b013e3181e56ddd. PMID: 20585266.

  16. Kotte A, Joshi G, Fried R, Uchida M, Spencer A, Woodworth KY, Kenworthy T, Faraone SV, Biederman J (2013): Autistic traits in children with and without ADHD. Pediatrics. 2013 Sep;132(3):e612-22. doi: 10.1542/peds.2012-3947. PMID: 23979086; PMCID: PMC3876754. N = 469

  17. Mulligan A, Anney RJ, O’Regan M, Chen W, Butler L, Fitzgerald M, Buitelaar J, Steinhausen HC, Rothenberger A, Minderaa R, Nijmeijer J, Hoekstra PJ, Oades RD, Roeyers H, Buschgens C, Christiansen H, Franke B, Gabriels I, Hartman C, Kuntsi J, Marco R, Meidad S, Mueller U, Psychogiou L, Rommelse N, Thompson M, Uebel H, Banaschewski T, Ebstein R, Eisenberg J, Manor I, Miranda A, Mulas F, Sergeant J, Sonuga-Barke E, Asherson P, Faraone SV, Gill M (2009): Autism symptoms in Attention-Deficit/Hyperactivity Disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J Autism Dev Disord. 2009 Feb;39(2):197-209. doi: 10.1007/s10803-008-0621-3. PMID: 18642069. n = 2.020

  18. Ohnishi T, Kobayashi H, Yajima T, Koyama T, Noguchi K (2019): Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. Innov Clin Neurosci. 2019 Sep 1;16(9-10):11-16. PMID: 32082943; PMCID: PMC7009330.

  19. Taipale H, Bergström J, Gèmes K, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M (2024): Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes. JAMA Netw Open. 2024 Mar 4;7(3):e242859. doi: 10.1001/jamanetworkopen.2024.2859. PMID: 38506810; PMCID: PMC10955386. N = 221.714

  20. Castellanos, Tannock (2002): Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002 Aug;3(8):617-28.; PMID: 12154363 DOI: 10.1038/nrn896, S. 619

  21. Strehl et al. (2013): Neurofeedback, Kohlhammer

  22. Gadow KD, DeVincent CJ, Pomeroy J (2006): ADHD symptom subtypes in children with pervasive developmental disorder. J Autism Dev Disord. 2006 Feb;36(2):271-83. doi: 10.1007/s10803-005-0060-3. PMID: 16477513.

  23. Joshi, Wilens (2022): Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder. Child Adolesc Psychiatr Clin N Am. 2022 Jul;31(3):449-468. doi: 10.1016/j.chc.2022.03.012. PMID: 35697395. REVIEW

  24. Lee DO, Ousley OY (2006): Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):737-46. doi: 10.1089/cap.2006.16.737. PMID: 17201617. n = 83

  25. Lee J, Lee SI (2023):Unrecognized comorbid autism spectrum disorder in children initially diagnosed with only attention deficit hyperactivity disorder. Asian J Psychiatr. 2023 Jul;85:103629. doi: 10.1016/j.ajp.2023.103629. PMID: 37243986.

  26. Mohammadi, Ahmadi, Khaleghi, Zarafshan, Mostafavi, Kamali, Rahgozar, Ahmadi, Hooshyari, Alavi, Shakiba, Salmanian, Molavi, Sarraf, Hojjat, Mohammadzadeh, Amiri, Arman, Ghanizadeh (2019): Prevalence of Autism and its Comorbidities and the Relationship with Maternal Psychopathology: A National Population-Based Study. Arch Iran Med. 2019 Oct 1;22(10):546-553.

  27. Merrill RM, Merrill AW, Madsen M (2022): Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury. Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. PMID: 36277995; PMCID: PMC9586798. N = 382.488

  28. Lundström, Mårland, Kuja-Halkola, Anckarsäter, Lichtenstein, Gillberg, Nilsson (2019): Assessing autism in females: The importance of a sex-specific comparison. Psychiatry Res. 2019 Sep 13:112566. doi: 10.1016/j.psychres.2019.112566. n = 30.392

  29. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012 Mar 30;61(3):1-19. PMID: 22456193.

  30. Panagiotidi, Overton, Stafford (2017): Co-Occurrence of ASD and ADHD Traits in an Adult Population.J Atten Disord. 2017 Aug 1:1087054717720720. doi: 10.1177/1087054717720720; n = 334

  31. Hara (2019): [Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder]. [Article in Japanese] Yakugaku Zasshi. 2019;139(11):1391-1396. doi: 10.1248/yakushi.19-00131.

  32. Kaye AD, Allen KE, Smith Iii VS, Tong VT, Mire VE, Nguyen H, Lee Z, Kouri M, Jean Baptiste C, Mosieri CN, Kaye AM, Varrassi G, Shekoohi S (2024): Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review. Cureus. 2024 Jul 2;16(7):e63671. doi: 10.7759/cureus.63671. PMID: 39092332; PMCID: PMC11293483. REVIEW

  33. Ahlberg R, Garcia-Argibay M, Taylor M, Lichtenstein P, D’Onofrio BM, Butwicka A, Hill C, Cortese S, Larsson H, Du Rietz E (2023): Prevalence of sleep disorder diagnoses and sleep medication prescriptions in individuals with ADHD across the lifespan: a Swedish nationwide register-based study. BMJ Ment Health. 2023 Aug;26(1):e300809. doi: 10.1136/bmjment-2023-300809. PMID: 37657817; PMCID: PMC10577710. N = 145.490, N = 5.819.600

  34. ADHS, iPads, Schlaf und Konzentrationsprobleme: Im Licht neuer Erkenntnisse

  35. Sung, Hiscock, Sciberras, Efron (2008): Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family; Arch Pediatr Adolesc Med. 2008 Apr;162(4):336-42. doi: 10.1001/archpedi.162.4.336. n = 239

  36. Kostanecka-Endress, Woerner, Hajak, Rothenberger (2008): Tag und Nacht in Bewegung – Schlafverhalten hypermotorischer Kinder Tourette-Syndrom und hyperkinetisches Syndrom; Monatsschrift Kinderheilkunde; December 2000, Volume 148, Issue 12, pp 1113–1128; zitiert nach Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 187

  37. Schlüter, Buschatz, Kahlen, Dieffenbach, Trowitzsch (1999): Polysomnographie bei aufmerksamkeitsgestörten und hyperaktiven Kindern (Attention Deficit Hyperactivity Disorder, ADHD); Somnologie – Schlafforschung und Schlafmedizin, May 1999, Volume 3, Issue 3, pp 140–147

  38. Kim, Lee, Sung, Jung, Pak (2019): Prevalence of attention deficit hyperactivity disorder symptoms in narcolepsy: a systematic review. Sleep Med. 2019 Aug 3;65:84-88. doi: 10.1016/j.sleep.2019.07.022.

  39. Nishino, Sakai (2016): Modulations of Ventral Tegmental Area (VTA) Dopaminergic Neurons by Hypocretins/Orexins: Implications in Vigilance and Behavioral Control In: Monti, Pandi-Perumal, Chokroverty (Herausgeber) (2016): Dopamine and Sleep: Molecular, Functional, and Clinical Aspects, 65-90, 75

  40. Kooij (2019): ADHD and Sleep Webinar

  41. Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 mit Verweis auf Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8.

  42. Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 17

  43. Prävalenz von Schlafstörungen unter Erwerbstätigen in Deutschland nach Geschlecht und Altersgruppe im Jahr 2008, Statista

  44. Shen, Li, Xue, Li, Li, Jiang, Sheng, Wang (2022): Nutritional complexity in children with ADHD related morbidities in China: A cross-sectional study. Asia Pac J Clin Nutr. 2022 Mar;31(1):108-117. doi: 10.6133/apjcn.202203_31(1).0012. PMID: 35357109.

  45. http://www.adhspedia.de/wiki/Fehldiagnosen

  46. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, 2006, Seite 40, unter Bezug auf Krause et al. 1998.

  47. Leitlinie der Arbeitsgemeinschaft ADHS der Kinder- und Jugendärzte e.V., Stand 2014

  48. https://www.klinikum.uni-heidelberg.de/AG-Anaesthesie-und-Schlafapnoe.114157.0.html, nicht mehr online

  49. Smith, Gozal, Hunter, Kheirandish-Gozal (2017): Parent-Reported Behavioral and Psychiatric Problems Mediate the Relationship between Sleep-Disordered Breathing and Cognitive Deficits in School-Aged Children. Front Neurol. 2017 Aug 11;8:410. doi: 10.3389/fneur.2017.00410. eCollection 2017.

  50. Hudgins (2003): Experiential Treatment for PTSD. New York, NY: Springer Publishing Company, zitiert nach Böhm (2010/2012): Erfahrungen mit “SynestheticProcessing”/emoflex©; Heft 4/2010 „neuenAkzente“ des ADHS Deutschland e.V.

  51. Tempesta, Couyoumdjian, Curcio, Moroni, Marzano, De Gennaro, Ferrara (2010): Lack of sleep affects the evaluation of emotional stimuli. BrainRes Bull, n = 40

  52. Böhm (2010/2012): Erfahrungen mit “SynestheticProcessing”/emoflex©; Heft 4/2010 „neuenAkzente“ des ADHS Deutschland e.V.

  53. Kooij, Huss, Asherson, Akehurst, Beusterien, French, Sasané, Hodgkins (2012): Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012 Jul;16(5 Suppl):3S-19S. doi: 10.1177/1087054711435361.

  54. Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007): Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):371-7. doi: 10.1007/s00406-007-0712-8. PMID: 17902010. n = 140

  55. Chen, Hartman, Haavik, Harro, Klungsøyr, Hegvik, Wanders, Ottosen, Dalsgaard, Faraone, Larsson (2018): Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS One. 2018 Sep 26;13(9):e0204516. doi: 10.1371/journal.pone.0204516. PMID: 30256837; PMCID: PMC6157884. N = 5.551.807, 18 bis 64 Jahre

  56. Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K (2018): Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176-186. doi: 10.1111/acps.12845. PMID: 29266167; PMCID: PMC5838558.

  57. Roy, Oldehinkel, Verhulst; Ormel, Hartman (2014): Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression; J Clin Psychiatry. 2014 Feb;75(2):e108-13. doi: 10.4088/JCP.13m08648.; n = 1584

  58. Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8., zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009

  59. Adzrago D, Sulley S, Williams F (2025): Mental health in children with and without ADHD: the role of physical activity and parental nativity. Child Adolesc Psychiatry Ment Health. 2025 Jan 18;19(1):2. doi: 10.1186/s13034-025-00859-8. PMID: 39827157; PMCID: PMC11743031.

  60. Häufigkeit der Komorbidität bei Kindern mit ADHS nach Hudziak und Todd, 2001, zitiert aus Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 16

  61. adhs-chaoten; Thread: ADS / ADHS und saisonale Depression / Winterdepression

  62. Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 , Seite 313 unter Verweis auf Rösler, Heßlinger, Philipsen (2007): ADHS im Erwachsenenalter. In: Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen – State of the Art. 2. Auflage. München: Urban & Fischer, 2007

  63. Faraone, APA 2006: Massachusetts General Hospital Study, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009

  64. Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C (2012): The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012 Apr;42(4):875-87. doi: 10.1017/S003329171100153X. PMID: 21846424; PMCID: PMC3383088. N = 34.000

  65. Ohnishi, Kobayashi, Yajima, Koyama, Noguchi (2020): Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. Innov Clin Neurosci. 2019 Sep 1;16(9-10):11-16. PMID: 32082943; PMCID: PMC7009330. N = 575

  66. Endrass, G (2024): ADHS aktuell – Mythen und Bedenken versus Fakten; NeuroTransmitter 2024; 35 (1-2)

  67. Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM (2022): The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One. 2022 Nov 4;17(11):e0277175. doi: 10.1371/journal.pone.0277175. PMID: 36331985; PMCID: PMC9635752.

  68. Lundin C, Wikman A, Wikman P, Kallner HK, Sundström-Poromaa I, Skoglund C (2023): Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2023 Jun;62(6):665-674. doi: 10.1016/j.jaac.2022.07.847. PMID: 36332846. n = 792.913

  69. Orsolini L, Longo G, Volgare R, Piergentili S, Servasi M, Perugi G, Volpe U (2024): Cyclothymic affective temperament and low positive attitude coping strategies as predictors of comorbid depressive symptomatology in adult ADHD patients. J Affect Disord. 2024 Nov 15;365:417-426. doi: 10.1016/j.jad.2024.08.083. PMID: 39154981.

  70. Callovini T, Di Nicola M, Pepe M, Crocamo C, Bartoli F, Sani G, Carrà G (2024): Influence of temperament and emotional dysregulation on depressive symptoms in adults with attention-deficit/hyperactivity disorder: A structural equation modelling analysis. J Psychiatr Res. 2024 Dec;180:227-233. doi: 10.1016/j.jpsychires.2024.10.019. PMID: 39454489.

  71. Miesch, Deister (2018): Die Aufmerksamkeitsdefizit- und Hyperaktivitätsstörung (ADHS) in der Erwachsenenpsychiatrie: Erfassung der ADHS-12-Monatsprävalenz, der Risikofaktoren und Komorbidität bei ADHS; Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: Data on 12-month prevalence, risk factors and comorbidity; Fortschr Neurol Psychiatr. 2018 Feb 28. doi: 10.1055/s-0043-119987. DOI: 10.1055/s-0043-119987, n = 166

  72. Chang KD, Steiner H, Ketter TA (2000): Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry. 2000 Apr;39(4):453-60. doi: 10.1097/00004583-200004000-00014. PMID: 10761347.

  73. Avinoam R, Revital R, Doron B, Ella S, Yaacov B (2025): A Common Cause of ADHD and Bipolar Disorder (BD). Bipolar Disord. 2025 Sep;27(6):472-475. doi: 10.1111/bdi.70057. PMID: 40891025; PMCID: PMC12483310.

  74. Steinhausen, Rothenberger, Döpfner (Herausgeber) (2020): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Seite 204

  75. Pranjić M, Rahman N, Kamenetskiy A, Mulligan K, Pihl S, Arnett AB (2023): A systematic review of behavioral and neurobiological profiles associated with coexisting attention-deficit/hyperactivity disorder and developmental coordination disorder. Neurosci Biobehav Rev. 2023 Sep 12;153:105389. doi: 10.1016/j.neubiorev.2023.105389. PMID: 37704094. REVIEW

  76. Meachon EJ, Schaider JP, Alpers GW (2025): Motor skills in children with ADHD: overlap with developmental coordination disorder. BMC Psychol. 2025 Jan 18;13(1):53. doi: 10.1186/s40359-024-02282-8. PMID: 39827182; PMCID: PMC11742537.

  77. Fliers E, Rommelse N, Vermeulen SH, Altink M, Buschgens CJ, Faraone SV, Sergeant JA, Franke B, Buitelaar JK (2008): Motor coordination problems in children and adolescents with ADHD rated by parents and teachers: effects of age and gender. J Neural Transm (Vienna). 2008;115(2):211-20. doi: 10.1007/s00702-007-0827-0. PMID: 17994185. n = 755

  78. Fortnum K, Bourke M, Kwan M, O’Flaherty M, Dowling SK, Cairney J (2025): Comorbid Developmental Coordination Disorder and ADHD: The Effects on Emotional and Behavioural Problems in Young Children. Child Psychiatry Hum Dev. 2025 May 16. doi: 10.1007/s10578-025-01858-8. PMID: 40377831.

  79. Yasunaga M, Higuchi R, Kusunoki K, Mochizuki N (2025): Associations Among Developmental Coordination Disorder Traits, Neurodevelopmental Difficulties and University Personality Inventory Scores in Undergraduate Students at a Japanese National University: A Cross-Sectional Correlational Study. Brain Sci. 2025 Aug 21;15(8):895. doi: 10.3390/brainsci15080895. PMID: 40867226; PMCID: PMC12384660.

  80. Zentrales ADHS-Netz: Allgemeine Infos zu ADHS; “Welche weiteren komorbiden Probleme gibt es?”

  81. Gnanavel, Sharma, Kaushal, Hussain (2019): Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420.

  82. Biederman J (2005): Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005 Jun 1;57(11):1215-20. doi: 10.1016/j.biopsych.2004.10.020. PMID: 15949990. REVIEW

  83. Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, mit Verweis auf Hudziak, Todd 2001

  84. Mohammadi, Zarafshan, Khaleghi, Ahmadi, Hooshyari, Mostafavi, Ahmadi, Alavi, Shakiba, Salmanian (2019): Prevalence of ADHD and Its Comorbidities in a Population-Based Sample. J Atten Disord. 2019 Dec 13:1087054719886372. doi: 10.1177/1087054719886372. n = 30.532

  85. Sagar-Ouriaghli, Milavic, Barton, Heaney, Fiori, Lievesley, Singh, Santosh (2018): Comparing the DSM-5 construct of Disruptive Mood Dysregulation Disorder and ICD-10 Mixed Disorder of Emotion and Conduct in the UK Longitudinal Assessment of Manic Symptoms (UK-LAMS) Study. Eur Child Adolesc Psychiatry. 2018 Sep;27(9):1095-1104. doi: 10.1007/s00787-018-1149-5.

  86. Kain, Landerl, Kaufmann (2008): Komorbidität bei ADHS. Monatsschrift Kinderheilkunde,156, 757 – 767, zitiert nach Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071: Kommentare zu Romanos & Jans (2014). ADHS – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071

  87. Schmidt, S., Waldmann, H.-C., Petermann, F. & Brähler, E. (2010). Wie stark sind Erwachsene mit ADHS und komorbiden Störungen in ihrer gesundheitsbezogenen Lebensqualität beeinträchtigt? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 58, 9–21, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229

  88. Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8.

  89. Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009

  90. Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238

  91. Mayes SD, Pardej SK, Waschbusch DA (2024): Oppositional Defiant Disorder in Autism and ADHD. J Autism Dev Disord. 2024 Jul 27. doi: 10.1007/s10803-024-06437-9. PMID: 39066970. n = 2.400

  92. Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactvity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8.

  93. Hudziak und Todd, 2001, zitiert aus Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 16

  94. Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 173

  95. Masi, Manfredi, Nieri, Muratori, Pfanner, Milone (2017): A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression. J Clin Psychopharmacol. 2017 Aug 10. doi: 10.1097/JCP.0000000000000747; n = 40

  96. Sonuga-Barke, Bitsakou, Thompson (2010): Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory and delay-related impairments in Attention Deficit/Hyperactivity Disorder.

  97. Witthöft, Koglin, Petermann (2010): Zur Komorbidität von aggressivem Verhalten und ADHS. Kindheit und Entwicklung, 19, 218–227, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 232

  98. Salmanian, Mohammadi, Hooshyari, Mostafavi, Zarafshan, Khaleghi, Ahmadi, Alavi, Shakiba, Rahgozar, Safavi, Arman, Delpisheh, Mohammadzadeh, Hosseini, Ostovar, Hojjat, Armani, Talepasand, Amiri (2019): Prevalence, comorbidities, and sociodemographic predictors of conduct disorder: the national epidemiology of Iranian children and adolescents psychiatric disorders (IRCAP). Eur Child Adolesc Psychiatry. 2019 Dec 6. doi: 10.1007/s00787-019-01448-9.

  99. Shankman, Lewinsohn, Klein, Small, Seeley, Altman (2009): Subthreshold conditions as precursors for full syndrome disorders: A 15-year longitudinal study of multiple diagnostic classes. Journal of Child Psychology and Psychiatry, 50, 1485–1494, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 232

  100. Vuksanovic (2013): Die Aktivität der Hpothalamus-Hypophysen-Nebennierenrinden-Achse bei Aufmerksamkeits-Defizit und Hyperaktivitäts-Störung, Dissertation, Seite 102, 114

  101. Beesdo K, Knappe S, Pine DS (2009): Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009 Sep;32(3):483-524. doi: 10.1016/j.psc.2009.06.002. PMID: 19716988; PMCID: PMC3018839. REVIEW

  102. Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A (2018): Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966. PMID: 30056792; PMCID: PMC6340395. REVIEW

  103. Deng X, Ren H, Wu S, Jie H, Gu C (2024): Exploring the genetic and socioeconomic interplay between ADHD and anxiety disorders using Mendelian randomization. Front Psychiatry. 2024 Aug 6;15:1439474. doi: 10.3389/fpsyt.2024.1439474. PMID: 39165506; PMCID: PMC11333326.

  104. Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 174

  105. D’Agati, Curatolo, Mazzone (2019): Comorbidity between ADHD and anxiety disorders across the lifespan. Int J Psychiatry Clin Pract. 2019 Jun 24:1-7. doi: 10.1080/13651501.2019.1628277.

  106. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 53

  107. Wancata, Freidl, Fabrian (2011): Epidemiologie der Angststörungen, Journal für Neurologie Neurochirurgie und Psychiatrie, 2011; 12 (4), 332-335

  108. Murray, Caye, McKenzie, Auyeung, Murray, Ribeaud, Freeston, Eisner (2020): Reciprocal Developmental Relations Between ADHD and Anxiety in Adolescence: A Within-Person Longitudinal Analysis of Commonly Co-Occurring Symptoms. J Atten Disord. 2020 Mar 14:1087054720908333. doi: 10.1177/1087054720908333. PMID: 32172640.

  109. Fuller-Thomson, Carrique, MacNeil (2021): Generalized anxiety disorder among adults with attention deficit hyperactivity disorder. J Affect Disord. 2021 Nov 16:S0165-0327(21)01096-X. doi: 10.1016/j.jad.2021.10.020. PMID: 34799150. n = 6.989

  110. Wang F, Yang H, Li F, Zheng Y, Xu H, Wang R, Li Y, Cui Y (2024): Prevalence and comorbidity of anxiety disorder in school-attending children and adolescents aged 6-16 years in China. BMJ Paediatr Open. 2024 Mar 27;8(1):e001967. doi: 10.1136/bmjpo-2023-001967. PMID: 38538104; PMCID: PMC10982779.

  111. Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K (2018): Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176-186. doi: 10.1111/acps.12845. PMID: 29266167; PMCID: PMC5838558. N = 40.000

  112. Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM (2022): The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One. 2022 Nov 4;17(11):e0277175. doi: 10.1371/journal.pone.0277175. PMID: 36331985; PMCID: PMC9635752. METASTUDIE

  113. Hernández M, Levin FR, Campbell ANC (2025): ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions. CNS Drugs. 2025 May;39(5):457-472. doi: 10.1007/s40263-025-01168-6. PMID: 39979544. REVIEW

  114. McMahon C, Schweinle W, Anand V (2024): Substance Use Disorder in Adults with ADHD in South Dakota. S D Med. 2024 Aug;77(8):342-348. PMID: 39311728.

  115. Koura S, White A, Masdon J, Brewer KL, Parker-Cote JL, Meggs WJ (2023): Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county. J Am Coll Emerg Physicians Open. 2023 Aug 17;4(4):e13028. doi: 10.1002/emp2.13028. PMID: 37600902; PMCID: PMC10435894.

  116. Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K (2018): Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176-186. doi: 10.1111/acps.12845. PMID: 29266167; PMCID: PMC5838558. N = 1.701.206

  117. Md Yusop MR, Mohamed S, Jaris NH, Jamal A (2024): Factors associated with attention deficit hyperactivity disorder symptoms among patients with substance use in Malaysia. East Asian Arch Psychiatry. 2024 Dec;34(4):91-102. doi: 10.12809/eaap2426. PMID: 39743482.

  118. Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernández-Ruiz JJ (2001): Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson’s syndrome and of MPTP-treated marmosets. Eur J Neurosci. 2001 Dec;14(11):1827-32. doi: 10.1046/j.0953-816x.2001.01812.x. PMID: 11860478.

  119. Mailleux P, Vanderhaeghen JJ (1993): Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. J Neurochem. 1993 Nov;61(5):1705-12. doi: 10.1111/j.1471-4159.1993.tb09807.x. PMID: 7901331.

  120. Romero J, Berrendero F, Pérez-Rosado A, Manzanares J, Rojo A, Fernández-Ruiz JJ, de Yebenes JG, Ramos JA (2000): Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Life Sci. 2000;66(6):485-94. doi: 10.1016/s0024-3205(99)00618-9. PMID: 10794065.

  121. Rohner H, Gaspar N, Philipsen A, Schulze M (2023): Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis. Int J Environ Res Public Health. 2023 Jan 10;20(2):1275. doi: 10.3390/ijerph20021275. PMID: 36674031; PMCID: PMC9859173. METASTUDIE

  122. Victor R, Gondwal R, Avinash P, Singhania R (2023): Decoding the link between substance dependence and attention deficit hyperactivity disorder in adults: A cross-sectional study from North India. Ind Psychiatry J. 2023 Jul-Dec;32(2):397-401. doi: 10.4103/ipj.ipj_47_23. PMID: 38161447; PMCID: PMC10756592.

  123. Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue EJ, Victorri-Vigneau C, Guillou-Landreat M, Leboucher J; OPAL-Group; Challet-Bouju G, Cabelguen C (2024): ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor. Harm Reduct J. 2024 Sep 9;21(1):165. doi: 10.1186/s12954-024-01079-7. PMID: 39252018; PMCID: PMC11382469.

  124. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 107 f

  125. Manni, Cipollone, Pallucchini, Maremmani, Perugi, Maremmani (2019): Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD. Int J Environ Res Public Health. 2019 Oct 15;16(20). pii: E3911. doi: 10.3390/ijerph16203911.

  126. Heradstveit, Skogen, Hetland, Stewart, Hysing (2019): Psychiatric Diagnoses Differ Considerably in Their Associations With Alcohol/Drug-Related Problems Among Adolescents. A Norwegian Population-Based Survey Linked With National Patient Registry Data. Front Psychol. 2019 May 8;10:1003. doi: 10.3389/fpsyg.2019.01003. eCollection 2019. n = 9.408

  127. August, Winters, Realmuto, Fahnhorst, Botzet, Lee (2006): Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):824-32. doi: 10.1097/01.chi.0000219831.16226.f8. PMID: 16832319. n = 199

  128. Pomerleau, Downey, Stelson, Pomerleau (1995): Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder, Journal of Substance Abuse, Volume 7, Issue 3, 1995, Pages 373-378, ISSN 0899-3289, https://doi.org/10.1016/0899-3289(95)90030-6.

  129. Lambert, Hartsough, (1998): Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants. Journal of Learning Disabilities, 31(6), 533–544. https://doi.org/10.1177/002221949803100603

  130. Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 88

  131. http://de.statista.com/statistik/daten/studie/261015/umfrage/praevalenz-des-rauchens-in-deutschland-nach-geschlecht/

  132. Kollins, McClernon, Fuemmeler (2005): Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005 Oct;62(10):1142-7.

  133. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106

  134. Steinhausen, Rothenberger, Döpfner (2010): Handbuch ADHS, Seite 78

  135. Roman ML, Vansteene C, Poupon D, Gorwood P (2025): Detecting the comorbidity of attention deficit hyperactivity disorder (ADHD) in a population of outpatients with alcohol use disorder (AUD): The role of personality traits, age at first alcohol use and level of craving. Alcohol. 2025 Feb;122:63-70. doi: 10.1016/j.alcohol.2024.11.001. PMID: 39505078.

  136. Krause, Biermann, Krause (2002): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Alkoholikern. Nervenheilkunde 21 (2002): 156-159., zitiert nach Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106

  137. Lohit, Babu, Sharma, Rao, Sachin, Matkar (2019): Prevalence of Adult ADHD Co-morbidity in Alcohol Use Disorders in a General Hospital Setup. Indian J Psychol Med. 2019 Nov 11;41(6):523-528. doi: 10.4103/IJPSYM.IJPSYM_464_18. eCollection 2019 Nov-Dec.

  138. August, Winters, Realmuto, Fahnhorst, Botzet, Lee (2006): Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):824-32. doi: 10.1097/01.chi.0000219831.16226.f8. PMID: 16832319.

  139. Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 , Seite 313 unter Verweis auf Rösler, Heßlinger, Philipsen (2007): ADHS im Erwachsenenalter. In: Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen – State of the Art. 2. Auflage. München: Urban & Fischer, 2007

  140. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106 mwNw

  141. Biederman, Wilens, Mick, Milberger, Spencer, Faraone (1995): Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995 Nov;152(11):1652-8.

  142. Weiss et al. 1985, Gittelman et al. 1985, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009

  143. Martínez-Luna, Daigre, Palma-Álvarez, Perea-Ortueta, Grau-López, Roncero, Castell-Panisello, Ramos-Quiroga (2019): Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders. J Atten Disord. 2019 Sep 24:1087054719875787. doi: 10.1177/1087054719875787.

  144. Philipsen, Heßlinger, Tebartz van Elst: Aufmerksamkeitsdefizit-Hyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 Seite 313

  145. Lugoboni, Zamboni, Mantovani, Cibin, Tamburin (2020): Gruppo InterSERT di Collaborazione Scientifica. Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study. Eur Addict Res. 2020 Jan 29;1-11. doi: 10.1159/000505207. PMID: 31995807. n = 1.649

  146. Riedinger (2011): ADHS und Sucht im Erwachsenenalter

  147. Levin, Evans, Kleber (1998): Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998 Sep 1;52(1):15-25.

  148. Jacob, Haro, Koyanagi (2018): Relationship between attention-deficit hyperactivity disorder symptoms and problem gambling: A mediation analysis of influential factors among 7,403 individuals from the UK. J Behav Addict. 2018 Sep 21:1-11. doi: 10.1556/2006.7.2018.72. n = 7403

  149. So R, Sato Y, Hashimoto N, Furukawa TA (2023): Prevalence of suspected autism spectrum disorder and attention-deficit hyperactivity disorder in a Japanese clinical sample with gambling disorder: A cross-sectional study. PCN Rep. 2023 Aug 13;2(3):e131. doi: 10.1002/pcn5.131. PMID: 38867830; PMCID: PMC11114339.

  150. García-Marín, Campos, Cuéllar-Partida, Medland, Kollins, Rentería (2021): Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Sci Rep. 2021 Nov 19;11(1):22628. doi: 10.1038/s41598-021-01517-7. PMID: 34799595.

  151. Prof. Dr. Tobias Renner, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung Störungen des Sozialverhaltens; nicht mehr online

  152. Kessler, Adler, Barkley, Biederman, Conners, Demler, Faraone, Greenhill, Howes, Secnik, Spencer, Ustun, Walters, Zaslavsky (2006): The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 Apr;163(4):716-23. doi: 10.1176/ajp.2006.163.4.716. PMID: 16585449; PMCID: PMC2859678.

  153. Prävalenzraten des Konsums illegaler Drogen unter deutschen Erwachsenen - ausgewählten Substanzen im Jahr 2019, Statista

  154. Nikotinabhängigkeit, GenderMedWiki Uni Münster

  155. Alkoholabhängigkeit, GenderMedWiki Uni Münster

  156. Luderer, Sick, Kaplan-Wickel, Reinhard, Richter, Kiefer, Weber (2020): Prevalence Estimates of ADHD in a Sample of Inpatients With Alcohol Dependence. J Atten Disord. 2020 Dec;24(14):2072-2083. doi: 10.1177/1087054717750272. PMID: 29308693.

  157. Glass, Flory, Martin, Hankin, (2011). ADHD and comorbid conduct problems among adolescents: Associations with self-esteem and substance use. ADHD Attention Deficit and Hyperactivity Disorders, 3, 29–39, zitiert nach Sören Schmidt und Franz Petermann, ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229

  158. Brook, Duan, Zhang, Cohen, Brook, (2008). The association between attention deficit hyperactivity disorder in adolescence and smoking in Adulthood. American Journal on Addictions, 17, 54 – 59., zitiert nach Sören Schmidt und Franz Petermann, ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229

  159. Slobodin, Blankers, Kapitány-Fövény, Kaye, Berger, Johnson, Demetrovics, van den Brink, van de Glind (2020): Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test. Eur Addict Res. 2020;26(3):151-162. doi: 10.1159/000506334. PMID: 32074617.

  160. Prof. Dr. Tobias Renner, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung Störungen des Sozialverhaltens

  161. Kraus, Seitz, Rauschert (2020): Epidemiologischer Suchtsurvey Berlin 2018

  162. Deutsche Hauptstelle für Suchtfragen (2019): Jahrbuch Sucht 2019, S. 106

  163. Treur, Demontis, Smith, Sallis, Richardson, Wiers, Børglum, Verweij, Munafò (2019): Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization. Addict Biol. 2019 Nov 16:e12849. doi: 10.1111/adb.12849.

  164. Wimberley, Agerbo, Horsdal, Ottosen, Brikell, Als, Demontis, Børglum, Nordentoft, Mors, Werge, Hougaard, Bybjerg-Grauholm, Hansen, Mortensen, Thapar, Riglin, Langley, Dalsgaard (2019): Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction. 2019 Dec 5. doi: 10.1111/add.14910.

  165. Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.4

  166. Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.5

  167. Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.6

  168. Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.8

  169. Vaziri-Harami R, Khademi M, Zolfaghari A, Vaziri-Harami S (2024): Patterns of substance use and initiation timing in adults with substance abuse: a comparison between those with and without attention deficit hyperactivity disorder. Ann Med Surg (Lond). 2024 Jun 13;86(8):4397-4401. doi: 10.1097/MS9.0000000000002272. PMID: 39118714; PMCID: PMC11305728.

  170. Hässler, Irmisch: Biochemische Störungen bei Kindern mit AD(H)S, Seite 88, in Steinhausen (Hrsg.) (2000): Hyperkinetische Störungen bei Kindern, Jugendlichen und Erwachsenen, 2. Aufl., Kohlhammer

  171. Migueis DP, Lopes MC, Casella E, Soares PV, Soster L, Spruyt K (2023): Attention deficit hyperactivity disorder and restless leg syndrome across the lifespan: A systematic review and meta-analysis. Sleep Med Rev. 2023 Feb 27;69:101770. doi: 10.1016/j.smrv.2023.101770. PMID: 36924608. METASTUDIE

  172. Ghayad T, Mungo A, Hein M (2025): Prevalence and Clinical Impact of Restless Legs Syndrome in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Clocks Sleep. 2025 Sep 17;7(3):50. doi: 10.3390/clockssleep7030050. PMID: 40981213; PMCID: PMC12452460. REVIEW

  173. Oner, Dirik, Taner, Caykoylu, Anlar (2007): Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med. 2007 Nov;213(3):269-76. doi: 10.1620/tjem.213.269. PMID: 17984624. n = 87

  174. Cortese, Konofal, Lecendreux, Arnulf, Mouren, Darra, Dalla Bernardina (2005): Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005 Aug 1;28(8):1007-13. doi: 10.1093/sleep/28.8.1007. PMID: 16218085. REVIEW

  175. Zak, Fisher, Couvadelli, Moss, Walters (2009): Preliminary study of the prevalence of restless legs syndrome in adults with attention deficit hyperactivity disorder. Percept Mot Skills. 2009 Jun;108(3):759-63. doi: 10.2466/PMS.108.3.759-763. PMID: 19725311. n = 30

  176. Huang, Chen, Li, Wu, Chao, Guilleminault (2004): Sleep disorders in Taiwanese children with attention deficit/hyperactivity disorder. J Sleep Res. 2004 Sep;13(3):269-77. doi: 10.1111/j.1365-2869.2004.00408.x. PMID: 15339263. n = 88

  177. Picchietti, Underwood, Farris, Walters, Shah, Dahl, Trubnick, Bertocci, Wagner, Hening (1999): Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord. 1999 Nov;14(6):1000-7. doi: 10.1002/1531-8257(199911)14:6<1000::aid-mds1014>3.0.co;2-p. PMID: 10584676.

  178. Fulda S, Miano S. Time to rest a hypothesis? Accumulating evidence that periodic leg movements during sleep are not increased in children with attention deficit hyperactivity disorder (ADHD): results of a case-control study and a meta-analysis. Sleep. 2023 Mar 3:zsad046. doi: 10.1093/sleep/zsad046. Epub ahead of print. PMID: 36869787. METASTUDIE

  179. Didriksen, Thørner, Erikstrup, Pedersen, Paarup, Petersen, Hansen, Banasik, Nielsen, Hjalgrim, Jennum, Sørensen, Burgdorf, Ullum (2019): Self-reported restless legs syndrome and involuntary leg movements during sleep are associated with symptoms of attention deficit hyperactivity disorder. Sleep Med. 2019 Feb 11;57:115-121. doi: 10.1016/j.sleep.2019.01.039. n = 25.336

  180. Picchietti, Allen, Walters, Davidson, Myers, Ferini-Strambi (2007): Restless legs syndrome: prevalence and impact in children and adolescents–the Peds REST study. Pediatrics. 2007 Aug;120(2):253-66. doi: 10.1542/peds.2006-2767. PMID: 17671050.

  181. Tilma, Thomsen, Ostergaard (2014): [A possible coexistence between restless legs syndrom and attention deficit hyperactivity disorder]. Ugeskr Laeger. 2014 Feb 17;176(4):V11120672. Danish. PMID: 25095868. REVIEW

  182. Konofal, Cortese, Marchand, Mouren, Arnulf, Lecendreux (2007): Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med. 2007 Nov;8(7-8):711-5. doi: 10.1016/j.sleep.2007.04.022. PMID: 17644481.

  183. Konofal, Lecendreux, Arnulf, Mouren (2004): Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004 Dec;158(12):1113-5. doi: 10.1001/archpedi.158.12.1113. PMID: 15583094.

  184. Lahat, Heyman, Livne, Goldman, Berkovitch, Zachor (2011): Iron deficiency in children with attention deficit hyperactivity disorder. Isr Med Assoc J. 2011 Sep;13(9):530-3. PMID: 21991711.

  185. Millichap, Yee, Davidson (2006): Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol. 2006 Mar;34(3):200-3. doi: 10.1016/j.pediatrneurol.2005.09.001. PMID: 16504789.

  186. Cortese, Angriman (2014): Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: is there a link? Postgrad Med. 2014 Jul;126(4):155-70. doi: 10.3810/pgm.2014.07.2793. PMID: 25141253. REVIEW

  187. Trenkwalder, Paulus (2010): Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55. PMID: 20531433. REVIEW

  188. Picchietti MA, Picchietti DL. Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment. Sleep Med. 2010 Aug;11(7):643-51. doi: 10.1016/j.sleep.2009.11.014. PMID: 20620105. REVIEW

  189. Simakajornboon, Kheirandish-Gozal, Gozal (2009): Diagnosis and management of restless legs syndrome in children. Sleep Med Rev. 2009 Apr;13(2):149-56. doi: 10.1016/j.smrv.2008.12.002. PMID: 19186083; PMCID: PMC2911577. REVIEW

  190. Connor, Boyer, Menzies, Dellinger, Allen, Ondo, Earley (2003): Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003 Aug 12;61(3):304-9. doi: 10.1212/01.wnl.0000078887.16593.12. PMID: 12913188.

  191. Allen, Earley (2007): The role of iron in restless legs syndrome. Mov Disord. 2007;22 Suppl 18:S440-8. doi: 10.1002/mds.21607. Erratum in: Mov Disord. 2008 Jun;23(8):1200-2. PMID: 17566122. REVIEW

  192. Konofal, Lecendreux, Deron, Marchand, Cortese, Zaïm, Mouren, Arnulf (2008): Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008 Jan;38(1):20-6. doi: 10.1016/j.pediatrneurol.2007.08.014. PMID: 18054688. n = 23

  193. Ferré, Guitart, Quiroz, Rea, García-Malo, Garcia-Borreguero, Allen, Earley (2021): Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Sleep Med Clin. 2021 Jun;16(2):249-267. doi: 10.1016/j.jsmc.2021.02.012. PMID: 33985651.

  194. P LMB, E SSA, Castro-Villacañas, Garcia-Borreguero (2021): Restless Legs Syndrome: Challenges to Treatment. Sleep Med Clin. 2021 Jun;16(2):269-277. doi: 10.1016/j.jsmc.2021.02.003. PMID: 33985652.

  195. England, Picchietti, Couvadelli, Fisher, Siddiqui, Wagner, Hening, Lewin, Winnie, Cohen, Walters (2011): L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children. Sleep Med. 2011 May;12(5):471-7. doi: 10.1016/j.sleep.2011.01.008. PMID: 21463967; PMCID: PMC3094572.

  196. Konofal, Arnulf, Lecendreux, Mouren (2005): Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol. 2005 May;32(5):350-1. doi: 10.1016/j.pediatrneurol.2004.11.007. PMID: 15866437.

  197. Kamran L, Golestaneh SM (2025): Epidemiology and Cognitive Function in Adults with ADHD and Cognitive Disengagement Syndrome. Percept Mot Skills. 2025 Sep 19:315125251370101. doi: 10.1177/00315125251370101. PMID: 40973112. N = 690

  198. Büber, Başay, Şenol (2020): The prevalence and comorbidity rates of specific learning disorder among primary school children in Turkey. Nord J Psychiatry. 2020 Aug;74(6):453-460. doi: 10.1080/08039488.2020.1740782. PMID: 32186228. n = 1.041

  199. Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071:

  200. Kommentare zu Romanos & Jans (2014). ADHS-HI – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071

  201. Ciulkinyte A, Mountford HS, Fontanillas P; 23andMe Research Team; Bates TC, Martin NG, Fisher SE, Luciano M (2024): Genetic neurodevelopmental clustering and dyslexia. Mol Psychiatry. 2024 Jul 15. doi: 10.1038/s41380-024-02649-8. PMID: 39009701.

  202. van Bergen E, de Zeeuw EL, Hart SA, Boomsma DI, de Geus EJC, Kan KJ (2025): *Co-Occurrence and Causality Among ADHD, Dyslexia, and Dyscalculia. Psychol Sci. 2025 Mar;36(3):204-217. doi: 10.1177/09567976241293999. PMID: 40098496.

  203. McGrath, Stoodley (2019): Are there shared neural correlates between dyslexia and ADHD? A meta-analysis of voxel-based morphometry studies. J Neurodev Disord. 2019 Nov 21;11(1):31. doi: 10.1186/s11689-019-9287-8.

  204. Sarisuta P, Chunsuwan I, Hansakunachai T, Sritipsukho P. Attention-deficit/hyperactive-impulsive disorder symptoms among grade 1 students with reading disorder in Thailand. Clin Exp Pediatr. 2023 Nov;66(11):485-492. doi: 10.3345/cep.2023.00773. PMID: 37873565; PMCID: PMC10626022. N = 703

  205. Horowitz-Kraus, Hershey, Kay, DiFrancesco (2019): Differential effect of reading training on functional connectivity in children with reading difficulties with and without ADHD comorbidity. J Neurolinguistics. 2019 Feb;49:93-108. doi: 10.1016/j.jneuroling.2018.09.002.

  206. Schuhmacher (2016): Fehler muss man sehen! Visuelle Funktions- und Informationsverarbeitungsstörungen bei Schulkindern. Vortrag, Youtube

  207. Haider S, Mondal T, Loffredo CA, Korba B, Nawaz I, Azam M, Sur T, Ghosh S (2025): Epidemiological Investigation on the Clinical Status of the Developmental Dyslexia and ADHD Comorbidity among School-Age Children in Pakistan. Open J Epidemiol. 2025 Aug;15(3):528-541. doi: 10.4236/ojepi.2025.153033. PMID: 40855875; PMCID: PMC12373264.

  208. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 40

  209. Daucourt, Erbeli, Little, Haughbrook, Hart (2020): A Meta-Analytical Review of the Genetic and Environmental Correlations between Reading and Attention-Deficit Hyperactivity Disorder Symptoms and Reading and Math. Sci Stud Read. 2020;24(1):23-56. doi: 10.1080/10888438.2019.1631827. PMID: 32189961; PMCID: PMC7079676. METASTUDIE

  210. Kanevski M, Booth JN, Stewart TM, Rhodes SM (2024): Cognitive heterogeneity in Attention Deficit Hyperactivity Disorder: Implications for maths. Br J Dev Psychol. 2024 Nov;42(4):596-621. doi: 10.1111/bjdp.12517. PMID: 39166844.

  211. Gaye F, Harmon SL, Cole AM, Marsh CL, Liu Q, Mcintosh A, Kofler MJ (2025): Examining the roles of working memory and trait anxiety on math achievement in children with ADHD. Neuropsychology. 2025 Mar;39(3):259-274. doi: 10.1037/neu0000994. PMID: 40063373; PMCID: PMC11926614.

  212. Lauth: ADHS bei Erwachsenen: Diagnostik und Behandlung von Aufmerksamkeits-/ Hyperaktivitätsstörungen, Seite 97

  213. Varheenmaa M, Lehto SM, Rizzo P, Steinhausen HC, Drechsler R, Brem AK (2024): Facial emotion recognition in children with attention deficit hyperactivity disorder. Nord J Psychiatry. 2024 Oct;78(7):634-643. doi: 10.1080/08039488.2024.2403589. PMID: 39294899; PMCID: PMC11458127.

  214. Mansour S, Mwafi N, Al-Tawarah N, Masoud B, Ab{u-Tapanjeh H, Alkhawaldeh I, Qawaqzeh M, Amro R, Mazahreh S (2023): PREVALENCE OF LEFT/RIGHT CONFUSION AMONG MEDICAL STUDENTS IN MUTAH UNIVERSITY- JORDAN. Georgian Med News. 2023 Nov;(344):85-89. PMID: 38236104.

  215. Meier, Pavlova, Dalsgaard, Nordentoft, Mors, Mortensen, Uher (2018): Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood. Br J Psychiatry. 2018 Sep;213(3):555-560. doi: 10.1192/bjp.2018.111.

  216. Fahrendorff AM, Pagsberg AK, Kessing LV, Maigaard K (2023): Psychiatric comorbidity in patients with pediatric bipolar disorder - A systematic review. Acta Psychiatr Scand. 2023 Mar 20. doi: 10.1111/acps.13548. PMID: 36941106.

  217. Mishra VC, Solanki G, Singh D, Goyal MK (2023): Prevalence and clinical correlates of co-morbid attention deficit hyperactivity disorder in euthymic adults with bipolar disorder: A cross-sectional study. Indian J Psychiatry. 2023 Nov;65(11):1129-1136. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_647_23. PMID: 38249150; PMCID: PMC10795658. N = 110

  218. Pinna, Visioli, Rago, Manchia, Tondo, Baldessarini (2018): Attention deficit-hyperactivity disorder in adult bipolar disorder patients. J Affect Disord. 2018 Sep 17;243:391-396. doi: 10.1016/j.jad.2018.09.038.

  219. Hossain, Mainali, Bhimanadham, Imran, Ahmad, Patel (2019): Medical and Psychiatric Comorbidities in Bipolar Disorder: Insights from National Inpatient Population-based Study. Cureus. 2019 Sep 12;11(9):e5636. doi: 10.7759/cureus.5636.

  220. Grigoroiu-Serbanescu, Giaroli, Thygesen, Shenyan, Bigdeli, Bass, Diaconu, Neagu, Forstner, Degenhardt, Herms, Nöthen, McQuillin (2019): Predictive power of the ADHD GWAS 2019 polygenic risk scores in independent samples of bipolar patients with childhood ADHD. J Affect Disord. 2019 Nov 23. pii: S0165-0327(19)32310-9. doi: 10.1016/j.jad.2019.11.109.

  221. O’Connell, Shadrin, Bahrami, Smeland, Bettella, Frei, Krull, Askeland, Walters, Davíðsdóttir, Haraldsdóttir, Guðmundsson, Stefánsson, Fan, Steen, Reichborn-Kjennerud, Dale, Stefánsson, Djurovic, Andreassen (2019): Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Mol Psychiatry. 2019 Dec 2. doi: 10.1038/s41380-019-0613-z. n = 105.000

  222. Adamis D, Kasianenko D, Usman M, Saleem F, Wrigley M, Gavin B, McNicholas F (2023): Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD). J Atten Disord. 2023 Mar 16:10870547231161531. doi: 10.1177/10870547231161531. PMID: 36927130. n = 147

  223. Mannuzza, Klein, Bessler, Malloy, LaPadula (1993): Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993 Jul;50(7):565-76. doi: 10.1001/archpsyc.1993.01820190067007. PMID: 8317950. n = 103

  224. Nach ADHS-Netzwerkstudie “Persönlichkeitsstörungen”, n = 156, zitiert nach NICOLAY (2009); IPSM-adhs Grundlagen, Teil 3

  225. Buitelaar, Posthumus, Bijlenga, Buitelaar (2019): The Impact of ADHD Treatment on Intimate Partner Violence in a Forensic Psychiatry Setting. J Atten Disord. 2019 Oct 16:1087054719879502. doi: 10.1177/1087054719879502.

  226. Matthies S, van Elst LT, Feige B, Fischer D, Scheel C, Krogmann E, Perlov E, Ebert D, Philipsen A (2011): Severity of childhood attention-deficit hyperactivity disorder–a risk factor for personality disorders in adult life? J Pers Disord. 2011 Feb;25(1):101-14. doi: 10.1521/pedi.2011.25.1.101. PMID: 21309626.

  227. Kuja-Halkola R, Lind Juto K, Skoglund C, Rück C, Mataix-Cols D, Pérez-Vigil A, Larsson J, Hellner C, Långström N, Petrovic P, Lichtenstein P, Larsson H (2021): Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes. Mol Psychiatry. 2021 Jan;26(1):341-349. doi: 10.1038/s41380-018-0248-5. PMID: 30323291; PMCID: PMC7815504.

  228. Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schäfer H, Schmidtke A, Böning J, Lesch KP (2007): Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):309-17. doi: 10.1007/s00406-007-0722-6. PMID: 17401730.

  229. Ditrich I, Philipsen A, Matthies S (2021): Borderline personality disorder (BPD) and attention deficit hyperactivity disorder (ADHD) revisited - a review-update on common grounds and subtle distinctions. Borderline Personal Disord Emot Dysregul. 2021 Jul 6;8(1):22. doi: 10.1186/s40479-021-00162-w. PMID: 34229766; PMCID: PMC8261991. REVIEW

  230. Weibel S, Nicastro R, Prada P, Cole P, Rüfenacht E, Pham E, Dayer A, Perroud N (2018): Screening for attention-deficit/hyperactivity disorder in borderline personality disorder. J Affect Disord. 2018 Jan 15;226:85-91. doi: 10.1016/j.jad.2017.09.027. PMID: 28964997.

  231. Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, Barth J, Schmahl C, Bohus M (2008): Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry. 2008 Feb;192(2):118-23. doi: 10.1192/bjp.bp.107.035782. PMID: 18245028.

  232. Fossati A, Novella L, Donati D, Donini M, Maffei C (2002): History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry. 2002 Sep-Oct;43(5):369-77. doi: 10.1053/comp.2002.34634. PMID: 12216012.

  233. Broughton T, Lambert E, Wertz J, Agnew-Blais J (2025): Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. Br J Psychiatry. 2025 Jun;226(6):410-417. doi: 10.1192/bjp.2025.104. PMID: 40528384; PMCID: PMC7617793. N = 715

  234. ADHS Deutschland Selbsthilfe Aachen. Abgerufen am 26.01.2024

  235. Rapanelli M, Frick L, Pogorelov V, Ohtsu H, Bito H, Pittenger C (2017): Histamine H3R receptor activation in the dorsal striatum triggers stereotypies in a mouse model of tic disorders. Transl Psychiatry. 2017 Jan 24;7(1):e1013. doi: 10.1038/tp.2016.290. PMID: 28117842; PMCID: PMC5545743.

  236. Magdi HM, Abousoliman AD, Lbrahim AM, Elsehrawy MG, El-Gazar HE, Zoromba MA (2025): Attention-deficit/hyperactivity disorder and post-traumatic stress disorder adult comorbidity: a systematic review. Syst Rev. 2025 Feb 14;14(1):41. doi: 10.1186/s13643-025-02774-7. PMID: 39953536; PMCID: PMC11829347. REVIEW

  237. Wilson J, Fida D, Maurer R, Wiley A, Rajasekera T, Spagnolo P (2025): Sex Differences in the Comorbidity between Attention Deficit-Hyperactivity Disorder and Posttraumatic Stress Disorder: A Systematic Literature Review and Meta-Analysis. medRxiv [Preprint]. 2025 Jan 10:2025.01.10.25320323. doi: 10.1101/2025.01.10.25320323. Update in: Gen Hosp Psychiatry. 2025 Apr 12;95:32-39. doi: 10.1016/j.genhosppsych.2025.04.003. PMID: 39830260; PMCID: PMC11741499. METASTUDY

  238. Knight AR, Kim S, Currao A, Lebas A, Nowak MK, Milberg WP, Fortier CB (2025): Assessing Attention-Deficit/Hyperactivity Disorder in Post-9/11 Veterans: Prevalence, Measurement Correspondence, and Comorbidity With Posttraumatic Stress Disorder. Mil Med. 2025 Apr 23;190(5-6):e1106-e1113. doi: 10.1093/milmed/usae539. PMID: 39607449; PMCID: PMC12016034.

  239. Michalski SC, Huang Y, Srasuebkul P, Cvejic RC, Arnold SR, Trollor JN (2025): Predictors of mental illness onset in adolescents and adults with intellectual disability: A retrospective cohort study in New South Wales, Australia. Aust N Z J Psychiatry. 2025 Dec;59(12):1095-1105. doi: 10.1177/00048674251374483. PMID: 41015930; PMCID: PMC12634903.

  240. Hängen Übergewicht und ADHS bei Kindern zusammen?

  241. Reinblatt, Mahone, Tanofsky-Kraff, Lee-Winn, Yenokyan, Leoutsakos, Moran, Guarda, Riddle (2015): Pediatric loss of control eating syndrome: Association with attention-deficit/hyperactivity disorder and impulsivity. Int J Eat Disord. 2015 Sep;48(6):580-8. doi: 10.1002/eat.22404.

  242. Mohammadi, Mostafavi, Hooshyari, Khaleghi, Ahmadi, Molavi, Armani Kian, Safavi, Delpisheh, Talepasand, Hojjat, Pourdehghan, Ostovar, Hosseini, Mohammadzadeh, Salmanian, Alavi, Ahmadi, Zarafshan (2019): Prevalence, correlates and comorbidities of feeding and eating disorders in a nationally representative sample of Iranian children and adolescents. Int J Eat Disord. 2019 Nov 19. doi: 10.1002/eat.23197. n = 27.111

  243. Schiros A, Antshel KM (2022): The relationship between anorexia nervosa and bulimia nervosa, attention deficit/hyperactivity disorder, and suicidality in college students. Eur Eat Disord Rev. 2022 Dec 5. doi: 10.1002/erv.2962. PMID: 36468533. n = 342.432

  244. Namimi-Halevi C, Dor C, Stark AH, Dichtiar R, Bromberg M, Sinai T (2023): Attention-deficit hyperactivity disorder is associated with disordered eating in adolescents. Pediatr Res. 2023 Dec 4. doi: 10.1038/s41390-023-02925-3. PMID: 38049648.

  245. Wang S, Yao B, Zhang H, Xia L, Yu S, Peng X, Xiang D, Liu Z (2023): Comorbidity of epilepsy and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Neurol. 2023 Jun 16. doi: 10.1007/s00415-023-11794-z. PMID: 37326829.

  246. Fu J, Li Q, Zhang G, Yang Z, Qin J (2025): Neuropsychiatric disorders in Chinese pediatric tuberous sclerosis complex patients associated with drug-resistant epilepsy: A TAND checklist-based survey. Epilepsy Behav Rep. 2025 Apr 3;30:100765. doi: 10.1016/j.ebr.2025.100765. PMID: 40242083; PMCID: PMC12001132.

  247. Ashjazadeh, Sahraeian, Sabzgolin, Asadi-Pooya (2019): Attention-deficit hyperactivity disorder in adults with epilepsy. Epilepsy Behav. 2019 Nov 4;101(Pt A):106543. doi: 10.1016/j.yebeh.2019.106543. n = 200

  248. Ahlqvist VH, Dardani C, Madley-Dowd P, Forbes H, Rast J, Zhong C, Gardner RM, Dalman C, Lyall K, Newschaffer C, Tomson T, Lundberg M, Berglind D, Davies NM, Lee BK, Magnusson C, Rai D (2024): Psychiatric comorbidities in epilepsy: population co-occurrence, genetic correlations and causal effects. Gen Psychiatr. 2024 Jan 30;37(1):e101201. doi: 10.1136/gpsych-2023-101201. PMID: 39228867; PMCID: PMC11369844. N = 7.628.495

  249. Dunbar, Lee, Maheshwari (2019): High Yield of Screening for ADHD in the Epilepsy Monitoring Unit. J Atten Disord. 2019 Nov 9:1087054719886359. doi: 10.1177/1087054719886359.

  250. Uliel-Sibony S, Chernuha V, Latzer IT, Leitner Y (2023): Epilepsy and attention-deficit/hyperactivity disorder in children and adolescents: An overview of etiology, prevalence, and treatment. Front Hum Neurosci. 2023 Apr 11;17:1021605. doi: 10.3389/fnhum.2023.1021605. PMID: 37113319; PMCID: PMC10126237.

  251. Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, Geoffray MM, Jurek L (2021): Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021 May 1;78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799. PMID: 33625499; PMCID: PMC7905700. METASTUDY

  252. Schulze JB, Simnacher F, Müller TJ, Kirchebner J, Quatela F, Mikutta C, Euler S, von Känel R, Günther MP (2025): ADHD and schizophrenia: Mere prodromal variant or homogeneous subgroup? Schizophr Res Cogn. 2025 Jun 18;42:100374. doi: 10.1016/j.scog.2025.100374. PMID: 40605957; PMCID: PMC12214124.

  253. Jeon SM, Lee DY, Cha S, Kwon JW (2023): Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder. JAMA Netw Open. 2023 Nov 1;6(11):e2345793. doi: 10.1001/jamanetworkopen.2023.45793. PMID: 38032637; PMCID: PMC10690465. N = 211.705

  254. Arican I, Bass N, Neelam K, Wolfe K, McQuillin A, Giaroli G (2019): Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia. Acta Psychiatr Scand. 2019 Jan;139(1):89-96. doi: 10.1111/acps.12948. PMID: 30105761; PMCID: PMC6412852. METASTUDY

  255. Arican I, Bass N, Neelam K, Wolfe K, McQuillin A, Giaroli G (2019): Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia. Acta Psychiatr Scand. 2019 Jan;139(1):89-96. doi: 10.1111/acps.12948. PMID: 30105761; PMCID: PMC6412852. N = 126

  256. Huang, Cheng, Tsai, Bai, Li, Lin, Su, Chen, Chen (2020): Familial coaggregation of major psychiatric disorders among first-degree relatives of patients with obsessive-compulsive disorder: a nationwide study. Psychol Med. 2020 Jan 7:1-8. doi: 10.1017/S0033291719003696. n = 89.500

  257. Sawitzky-Rose (2011): Assoziation von ADHS und Übergewicht bei Kindern und Jugendlichen in Deutschland: Ergebnisse der BELLA-Studie, Dissertation

  258. Barkley, Murphy (1998): ADHD: A Clinical Workbook; Milwaukee Young Adult Outcome Study, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009

  259. Skoglund, Kopp Kallner, Skalkidou, Wikström, Lundin, Hesselman, Wikman, Sundström Poromaa (2019): Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden. JAMA Netw Open. 2019 Oct 2;2(10):e1912463. doi: 10.1001/jamanetworkopen.2019.12463. n = 384.103

  260. Kartal E, Scott J, Morein-Zamir S (2025): Attitudes to possessions in emerging adults: Predictors of hoarding behaviours and beliefs. Br J Clin Psychol. 2025 Jul 1. doi: 10.1111/bjc.70003. PMID: 40590164.

  261. Kuwano, Nakao, Yonemoto, Yamada, Murayama, Okada, Honda, Ikari, Tomiyama, Hasuzawa, Kanba (2020): Clinical characteristics of hoarding disorder in Japanese patients. Heliyon. 2020 Mar 6;6(3):e03527. doi: 10.1016/j.heliyon.2020.e03527. PMID: 32181397; PMCID: PMC7063155. N = 71

  262. Grassi G, Scillitani E, Moradei C, Cecchelli C, van Ameringen M, Rodriguez CI (2025): Long-term changes of hoarding symptoms among adults with attention-deficit/hyperactivity disorder (ADHD) treated with methylphenidate. J Psychiatr Res. 2025 Oct;190:102-111. doi: 10.1016/j.jpsychires.2025.07.031. PMID: 40768777.

  263. Tsai, Chang, Chen, Jeng, Yang, Wu (2020): Associations Between Psychiatric Disorders and Enuresis in Taiwanese Children: A National Population-Based Study. Clin Epidemiol. 2020 Feb 18;12:163-171. doi: 10.2147/CLEP.S230537. PMID: 32110107; PMCID: PMC7035896.

  264. Septier, Stordeur, Zhang, Delorme, Cortese (2019): Association between suicidal spectrum behaviors and Attention-Deficit/Hyperactivity Disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2019 Aug;103:109-118. doi: 10.1016/j.neubiorev.2019.05.022.

  265. Levy, Kronenberg, Crosbie, Schachar (2020): Attention-deficit/hyperactivity disorder (ADHD) symptoms and suicidality in children: The mediating role of depression, irritability and anxiety symptoms. J Affect Disord. 2020 Mar 15;265:200-206. doi: 10.1016/j.jad.2020.01.022. PMID: 32090742. n = 1.517

  266. Yılmaz, Tamam (2018): Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat. 2018 Jul 24;14:1883-1889. doi: 10.2147/NDT.S159312. eCollection 2018. n = 132

  267. Spaull RVV, Kurian MA (2017): SLC6A3-Related Dopamine Transporter Deficiency Syndrome. 2017 Jul 27 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 28749637. REVIEW

  268. Ng J, Zhen J, Meyer E, Erreger K, Li Y, Kakar N, Ahmad J, Thiele H, Kubisch C, Rider NL, Morton DH, Strauss KA, Puffenberger EG, D’Agnano D, Anikster Y, Carducci C, Hyland K, Rotstein M, Leuzzi V, Borck G, Reith ME, Kurian MA (2014): Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain. 2014 Apr;137(Pt 4):1107-19. doi: 10.1093/brain/awu022. PMID: 24613933; PMCID: PMC3959557.

  269. Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA (2012): Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One. 2012;7(1):e28936. doi: 10.1371/journal.pone.0028936. PMID: 22279524; PMCID: PMC3260153.

  270. Walsh B, Tichenor SE, Gerwin KL (2025): The Significance of a Higher Prevalence of ADHD and ADHD Symptoms in Children Who Stutter. J Speech Lang Hear Res. 2025 Jun 5;68(6):2741-2758. doi: 10.1044/2025_JSLHR-24-00668. PMID: 40366906; PMCID: PMC12173216. N = 204

  271. Parikh AK, Musolff N, Tchack M, Rao B (2025): A Case-Control Study of Trichotillomania Patients Using a National Database. Skin Appendage Disord. 2025 Aug;11(4):379-384. doi: 10.1159/000543503. PMID: 40771450; PMCID: PMC12324719.

  272. Ghanizadeh A (2008): Association of nail biting and psychiatric disorders in children and their parents in a psychiatrically referred sample of children. Child Adolesc Psychiatry Ment Health. 2008 Jun 2;2(1):13. doi: 10.1186/1753-2000-2-13. PMID: 18513452; PMCID: PMC2435519. N = 450

  273. Chen, Pan, Huang, Hsu, Bai, Su, Li, Tsai, Cheng, Chen (2019): Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study. J Clin Psychiatry. 2019 Apr 30;80(3). pii: 18m12371. doi: 10.4088/JCP.18m12371.